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Abstract 
 
The activation of the innate immune response protects the host against viral infections. 
Innate recognition of viral signatures by pattern recognition receptors (PRRs) triggers the 
induction of type I Interferons (IFN) and results in a broad antiviral response. Here we show 
that various signaling components of the type I IFN pathway play a role in host defense 
against Langat virus (LGTV), a Flavivirus of the tick borne encephalitis virus (TBEV) 
serocomplex. IFN-β promoter stimulator-1 (IPS-1) and myeloid differentiation primary 
response 88 (Myd88) which are adaptor molecules for PRRs like retinoic acid induced gene-I 
(RIG-I), melanoma differentiation-associated gene 5 (MDA5) and Toll like receptors (TLRs) 
promote survival in systemic LGTV infection. Further regulatory elements of the type I IFN 
pathway such as IFN- regulatory factor (IRF) -3 and IRF-7 mediate local protection against 
viral replication and dissemination, even though they are dispensable for survival. Especially 
IRF-7 limits replication and spread of LGTV in the periphery and plays a protective role in the 
central nervous system (CNS). The absence of IRF-7 in the brain was associated with higher 
local inflammation and a shift in tissue tropism. Neurons are already known to be highly 
susceptible to LGTV infection, but here it was shown that especially astrocytes rely on IRF-7 
for protection against LGTV infection and propagation.  
IRF-7 normally provides a positive feedback loop to amplify the type I IFN response. The lack 
of IRF-7 was to date associated with decreased type I IFN production. Here it was shown 
that astrocytes are able to provide a potent local type I IFN response by an IRF-7 
independent mechanism. This thesis provides new insights in antiviral defenses in the 
absence of IRF-7, specifically in the CNS.    
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1. Introduction 
 
Infectious diseases are a major risk of public health and much effort has been invested 
into the development of therapeutics and precautionary measures [1]. New or reemerging 
pathogens provide new challenges and the development of therapeutics is comparably 
slow and limited at best [1–3]. Therefore it is important to increase the understanding 
about the most effective defense system against pathogens namely the immune system of 
the host. Profound knowledge of the immune response might help to consider new 
therapeutic options and provide alternative approaches to fight against infections more 
effectively [4–6]. The immune system itself is an evolutionary shaped and refined program 
which is distinguished roughly into innate and adaptive immunity [7].  
 
1.1. Innate Immunity 
 
The innate immune system is an ancient part of the immune system that allows unspecific 
but fast and efficient antiviral responses [7]. This is in contrast to adaptive immunity which 
shapes immunological memory upon pathogenic encounter and elicits specific immune 
responses upon infection with harmful agents [7].  
For the innate immune response distinct cell populations such as monocytes, 
macrophages, Dendritic cells (DCs) granulocytes and natural killer cells (NK cells) enable 
the organism to mount fast responses against invading pathogens as a first line of 
defense [8–10]. Whereas some cells show phagocytic activity, others are able to 
neutralize pathogens by neutrophil extracellular trap (NETs) formation [8][10]. However, 
cells of the innate immune system also contribute to the adaptive response [9]. DCs, 
neutrophils and macrophages for instance have a role in antigen presentation or secretion 
of inflammatory cytokines that induce T and B cell migration to the site of inflammation 
[8][11].  
The complement system is another part of the innate immune response and consists of 
soluble proteins which are able to bind pathogens.  [12]. Binding mediates direct pathogen 
killing by formation of pores in the cell membrane. Some components of the complement 
system  also act as chemokines and therefore activate and modulate the immune 
response [13,14].  
Cytokines and chemokines can also be released by immune cells as part of the adaptive 
as well as the innate immune response to mediate inflammatory and anti-inflammatory 
effects [15,16]. This initiates cell migration, cell differentiation as well as cell 
communication [17]. Similarly, small peptides called defensins support innate immunity by 
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unspecific antimicrobial effects within the cell [18]. The innate immunity therefore 
commands different weapons to fight against invading pathogens. 
 
1.1.1. Pathogen recognition by the innate immune system 
 
Pathogens such as bacteria, viruses or parasites can trigger cell intrinsic signaling 
pathways which lead to the production of defense molecules and the regulation of 
important cell functions like proliferation and survival [19–21]. Pathogen associated 
molecular patterns (PAMPS) like viral single stranded RNA (ssRNA), can be recognized 
by pathogen recognition receptors (PRRs) such as retinoic acid–inducible gene-I (RIG-I)-
like receptors (RLRs), Toll-like receptors (TLRs), NOD-like receptors (NLRs) and C-type 
lectin receptors (CLRs) [22]. 
TLRs and CLRs function as membrane bound receptors, whereas Retinoic acid-inducible 
gene-I (RIG-I) and Melanoma differentiation-associated protein 5 (MDA5) act as cytosolic 
sensor proteins [23]. RIG-I and MDA-5 oligomerize upon activation and signal 
downstream to adapter protein interferon beta (IFN-β) promotor stimulator-1 (IPS-1), also 
known as CARDIF or MAVS, which is located on the mitochondrial membrane [24]. IPS-1 
initiates a succession of phosphorylation steps with the involvement of different kinases 
such as TNF receptor associated factor 3 (TRAF3), TRAF family member-associated NF-
kappa-B activator (TANK), TANK binding kinase-1 (TBK-1) or IkB kinase ε (IKKε) [25]. 
These kinases activate interferon regulatory factor-3 (IRF-3) which homodimerizes and 
translocates into the nucleus to induce transcription of IFN-β and IFN-α4 genes by the 
binding of IRF-3 specific IFN stimulated response element (ISRE) motifs [26,27]. 
Interferons are produced and secreted by the cell and bind to IFN-α/β receptor (IFNAR) in 
a paracrine or autocrine manner [20]. This leads to the induction of the Jak/Stat pathway 
[28]. Latent Signal transducers and activators of transcription 1 (Stat1) and Stat2 are 
phosphorylated by Janus kinases, dimerize and form the IFN-stimulated gene factor 3 
(ISGF3) complex together with IRF-9 [29]. This complex induces the transcription of a 
broad range of IFN stimulated genes (ISGS), like 2'-5'-oligoadenylate synthetase (OAS), 
Viperin, Caspase-1 or IRF-7 which mediate multiple antiviral functions [30,31]. The 
induction of IRF-7 in infection leads to rapid IRF-7 assembly and activation by 
phosphorylation [32]. Homo- or hetero-dimerization with IRF-3 results in nuclear entry and 
enhanced type I IFN expression, as well as the induction or upregulation of ISGs [29].  
IRF-7 is also involved in other virus recognition pathways [33–35]. A family of sensor 
proteins called TLRs are able to recognize PAMPs and can then subsequently induce 
IRF-7 [36]. TLR7 and TLR9 are located in the endosomal membrane and signal via the 
adapter molecule Myeloid differentiation primary response gene 88 (Myd88) [36]. A 
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complex of different kinases assembles around the adapter which also recruits and 
phosphorylates IRF-7 [37]. This again leads to the induction of type I IFNs [37]. Another 
viral sensor known to recognize viral RNA is TLR3 [38]. This endosomal receptor signals 
downstream along the IKKε/TBK1 axis via the adapter molecule TIR-domain-containing 
adapter-inducing interferon-β (TRIF) and can also induce a type I IFN response [38].  
A signaling cascade that has been shown to support IFN production as well, is the mTOR 
pathway which promotes the activation of IRF-7 [33]. So far it is unclear if this is mediated 
by viral entry [33].  
By viral recognition the NF-κB pathway can be activated by Myd88/IRF-5 and TBK1/IKKε 
complexes [39]. It was shown that the IRF-7 promotor contains a Nuclear factor 'kappa-
light-chain-enhancer' of activated B-cells (NF-κB) binding site and therefore might be 
directly regulated by NF-κB [40]. Overall the induction of NF-κB leads to a signaling 
cascade that plays a role in inflammatory responses as well as cell proliferation and 
apoptosis and therefore antiviral defense [36].  
 
1.1.2. The Interferon system 
 
A class of immunomodulatory cytokines that are able to induce an antiviral state in 
infected as well as uninfected cells by innate immunity is the interferon family [41]. 
Activated by different signaling pathways, these cytokines exhibit a broad range of 
functions with an impact on cellular differentiation, growth and the production of defense 
molecules [41,42]. So far, three different subgroups of IFNs have been characterized. The 
type I IFN family is composed so far of 13 different IFN-α genes and 1 IFN-β gene, which 
are structurally and functionally related [43]. Less well known members like IFN-δ in pigs 
and IFN-τ in ruminants are species specific or like IFN-κ in keratinocytes and IFN-ε in 
placenta, region or cell type related [44–46]. Type I IFNs bind to the IFNAR, which is 
expressed nearly all cells [47]. Therefore all cells of the organism are able to react to type 
I IFN stimulation [47].  
IFN-γ is the only member of the type II IFN family, which displays antiviral function but no 
structural homologies to the type I IFN group [43]. The heterodimeric receptor that is 
bound by IFN-γ consists of the IFN-γ gamma receptor 1 (IFNGR1) and IFN-γ receptor 2 
(IFNGR2) chains [43]. IFN-γ is mainly secreted by activated T cells as well as NK cells 
and plays an important role in macrophage activation and the induction of major 
histocompatibility complex (MHC) expression [48,49]. 
A group of cytokines known before as Interleukin-29 (IL-29, IFN-λ1), IL-28A (IFN-λ2) and 
IL-28B (IFN-λ3) has been assigned to the IFN-λ family or type III IFNs [50]. These bind to 
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the IFNLR1 and IL-10Rβ receptor which are expressed mainly by epithelial cells. Mucosal 
tissues are therefore a specific target for type III IFNs [50]. 
The signaling of Interferons is mediated by the binding of individual receptors. 
Nevertheless, similar or even same signaling pathways are activated via the 
phosphorylation of Stat proteins by IFN signaling. Therefore identical or overlapping ISG 
profiles are induced by different IFN types (Fig.1) [51] 
 
 
Fig.1: Jak/Stat pathway signaling by Interferons. Type I, II and III IFNs bind to different receptor 
complexes but signal collectively via the JAK/STAT pathway. Different Stats homo- or 
heterodimerize upon phosphorylation and induce gene transcription by binding of ISRE or GAS 
sequences in antiviral genes. This leads to differentiated and individual antiviral responses against 
various pathogens [51].  
 
Activated Stat complexes bind to genes that contain ISRE or Gamma-IFN activated sites 
(GAS). This can be achieved by direct IFN signaling or by the induction of ISGs that bind 
to these sequences. Additionally, even though type I IFNs are bound to IFNAR1-IFNAR2 
complexes and signal mainly by Stat1/2 heterodimers which bind to ISRE sequences, also 
Stat1 and Stat3 homodimers can be accumulated by IFN-α and IFN-β. This leads to 
binding of a different gene set with GAS sequences. Different IFN families are therefore 
able, by receptor preference and Stat complex activation, to induce distinct but also 
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overlapping transcription profiles which subsequently leads to broader immune responses 
[51,52].  
 
1.1.3. Interferon regulatory factors (IRFs) 
 
IRFs are a family of transcription factors that are induced by IFN signaling or direct PAMP 
recognition of the cell [53]. These factors are very diverse in their function but share a N-
terminal DNA-binding domain (DBD) [26]. They induce a broad range of innate immune 
responses by different signaling pathways [54,55]. Some are constitutively expressed 
whereas others have to be induced and differences have been characterized for different 
cell types [32][55]. IRFs mediate activating or repressive functions which results in gene 
induction that is associated with cell growth, apoptosis or differentiation [55–58]. IRF-1 is a 
transcriptional activator that binds to cis elements of the IFN-β promotor and regulates the 
expression of various other inflammatory factors like MHC class I, IFN-α, OAS, protein 
kinase R (PKR), Caspase-1 and IL-15 genes [30][59]. IRF-2 provides a negative feedback 
loop for IRF-1 by transcriptional inhibition of IRF-1 induced genes [30]. This impacts 
cellular processes such as cell death or cell differentiation [30]. IRF-1 and IRF-2 are 
expressed in many different cell types [30][60]. 
In contrast, IRF-6 expression is cell type restricted. It can mainly be found in skin and is 
needed for keratinocyte differentiation. It therefore plays a role in skin and limb formation 
[55]. 
Another factor of the family, IRF-4, was identified originally in lymphoid cell populations 
[61]. IRF-4 influences many processes like B cell proliferation and T cell differentiation but 
also plays a role in PU.1 mediated macrophage signaling [61–63]. Similarly to IRF-4, IRF-
8 is only expressed by immune cells and interacts with transcription factor PU.1 [55]. It is 
responsible for various differentiation and proliferation processes in the myeloid cell 
population [55][64]. IRF-8 also activates the NF-κB signaling pathway in a TLR9 
dependent manner in DCs [65]. This NF-κB pathway is also initiated by IRF-5 signaling 
[66]. IRF-5 is e.g. expressed in B cells, DCs and monocytes and signals downstream of 
viral recognition by TLR7, TLR9 and TLR4 [67]. IRF-5 has also been shown to induce 
different and distinct subsets of IFN-α genes [68]. Interestingly, IRF-5 is not induced 
equally by viruses since it was activated by Newcastle disease virus (NDV) but not in 
Sendai virus (SeV) infection [68].  
IRF-3, IRF-7 and IRF-9 execute different and distinct functions in the type I IFN induction 
pathway like described briefly above. Due to their important role in the IFN induction 
pathway, the function of IRF-3 and IRF-7 proteins will be addressed in more detail.   
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Virus mediated IFN induction by IRF-3 and IRF-7  
 
IRF-3 and IRF-7 are important for effective and robust IFN responses [31][69]. IRF-3 was 
found to be merely responsible for the early IFN response, characterized by IFN-β and 
IFN-α4 production [70]. In contrast, IRF-7 induces a positive feedback loop and therefore 
leads to an amplification of the IFN signal [69,70]. Both factors activate different and 
distinct gene subsets and show overlapping but non redundant functions [26][69]. This 
sort of fine tuning for the IFN response is mediated by a regulation of IRF-7 on several 
levels [26]. IRF-3 is constitutively expressed in all tested cell types whereas IRF-7 has to 
be induced in most populations [26]. The exception are plasmacytoid DCs (pDCs), where 
basal expression of IRF-7 facilitates a fast type I IFN response [71]. Therefore genes that 
are only activated by IRF-7 but not IRF-3 can be considered as a delayed effector subset 
[69]. Different splice variants of IRF-7 also result in a more diverse protein subset [72]. 
However, mostly the 67 kDa mature IRF-7 protein can be found in differentiated cells and 
especially in lymphocytes [72]. In contrast, IRF-3 is only the size of 55 kDa [26]. 
Interestingly, both proteins show very different half-lives in the cell [69]. IRF-3 is very 
stable whereas IRF-7 contains an internal degradation signal which results in the low half-
live of roughly an hour and a relative self-limiting response [69].  
Another level of regulation is added by posttranslational modification [26]. Both proteins 
are phosphorylated on specific serine residues on their C-terminus [26]. This leads to a 
conformational change which results in the inactivation of intramolecular auto-inhibitory 
IRF associated domains (IAD) and also to a dimerization of these proteins [26]. Homo- or 
heterodimerization of IRF-3 and IRF-7 induce distinct subsets of IFN genes which show 
slight variances in their ISRE sequences [69]. IRF-7 has been shown to selectively induce 
IFN-α2, IFN-α5, IFN-α6 and IFN- α8, whereas IRF-3 activates mainly IFN-β and IFN-α4 
expression [27]. IRF-3 also readily recruits Co-activators like cAMP responsive element-
binding protein (CREB) which was not shown for IRF-7 [73].  This leads to signal 
amplification and fine tuning of antiviral responses [26][73].  
 
The role of IRF-3 and IRF-7 in viral infections 
 
The loss of IRF-3 and IRF-7 can result in impaired immune responses by the host [71]. It 
was shown that cells lacking IRF-3 or IRF-7 are more receptive to viral infections and that 
the Interferon production is decreased or abolished [54][71]. In vivo mouse models that 
lack  IRF-7 have been associated with lower systemic IFN responses in blood [54][71]. 
Additionally, a much higher susceptibility of these animals to different virus infections has 
been shown [54][71]. These effects might be due to differentiation defects in monocytes 
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which depend on IRF-7 for differentiation [74]. Another factor might be the delayed or 
impaired IFN production by pDCs, which are considered to be the main source for type I 
IFN [71]. In most cases these animals succumb to infection rapidly, for instance in herpes 
simplex virus -1 (HSV-1), West Nile virus (WNV) and Encephalomyocarditis virus (EMCV) 
infection [54][71]. Mutations in the IRF-7 gene in humans has also been associated with 
severe Influenza in younger children [75].  
 
1.2. Tick Borne Encephalitis Virus 
 
Infections with viruses of the Flaviviridae such as dengue virus (DENV), WNV, Japanese 
encephalitis virus (JeV), Zika virus (ZIKV) and tick-borne encephalitis virus (TBEV) are 
known to cause severe illness in humans all over the world [76,77]. In the last decades 
some of these viruses have attracted attention as emerging or re-emerging pathogens 
providing a risk to public health [78–80].  
 
1.2.1. Relevance of TBEV as emerging pathogen 
 
TBEV is mainly distributed across Asia and Europe and considered to be the most 
widespread arthropod-borne disease in central Europe [81]. Infections with TBEV are 
recorded in nearly all European states, but travel related infections into some of these 
countries have been noted [82,83]. Many infections go unnoticed not only because of the 
often subclinical course, but also the low awareness, like e.g. in Bulgaria [84]. A case 
study of patients presenting with encephalitis of unknown origin revealed TBEV positive 
cases [84]. This is especially important, since TBEV is one of the emerging diseases with 
case numbers increasing since 1990 [85]. Approximately 10.000-12.000 severe clinical 
cases are recorded annually in 30 different countries [85]. But not only case numbers, 
also the affected area is constantly expanding. In Germany the number of risk areas 
increased from 97 in 2005 to 137 endemic areas in 2012 [85,86]. Therefore, the European 
Commission added TBE to the list of communicable diseases for epidemiological 
surveillance in 2012 [87].  
 
1.2.2. Clinical manifestation  
 
The onset of symptoms is registered 7-14 days post infection, but might be shorter in case 
of infected milk consumption [88,89]. TBEV can lead to very different clinical outcomes in 
the infected host, depending on subtype, infection route and immune status of the host 
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[reviewed 88]. It is estimated that approximately 70-95% of the infections are subclinical 
and therefore not registered [90]. Other patients present with unspecific symptoms like 
headaches, nausea, fatigue and fever [88]. Infection with European strains often leads to 
a biphasic syndrome. The second phase affects 20-30% of the patients and the onset can 
emerge years after the primary infection but is characterized by more severe symptoms 
with impacts on the central nervous system (CNS) [88]. Patients can suffer from severe 
muscular pain, numbness, headaches, hearing defects and spinal paralysis leading to 
hemiplegia [88]. These symptoms are mostly due to the encephalitis or meningitis 
triggered by the virus and can lead in around 46 % of the clinical cases to neurological 
long term sequelae [91]. Though, case fatality rates are comparably low [88]. In contrast, 
infection with Far Eastern subtypes present with a monophasic disease where patients 
suffer from a more severe impact on the CNS with a much higher mortality [88]. Effective 
vaccination based on formalin inactivated European strains Neudoerfl (FSME Immun, 
Baxter) and K23 (Encepur, GlaxoSmithKline GmbH & Co. KG) are available in Europe 
[92,93]. A vaccination campaign in Austria reduced the number of TBEV cases very 
effectively [94]. Vaccination is a good precautionary measure since there is still no specific 
treatment licensed for TBEV [94]. This limits therapeutic options to symptomatic treatment 
[88].  
 
1.2.3. Classification  
 
Tick borne transmitted viruses are summarized in a group that varies in phylogeny, 
geographical distribution and the type of disease that is induced [95,96]. The classical 
TBEV subgroup is then clearly separated from phylogenetic similar viruses like Langat 
virus (LGTV), Powassan virus (POWV) and Omsk hemorrhagic fever virus (OHFV) 
[97,98]. All these viruses subtypes show a common structure, which is shared by all 
Flaviviridae [99].  
 
TBEV subtypes 
 
Overall three main groups have been defined: the Far-Eastern, the Siberian and the 
European subtypes [100]. Strains from different subgroups differ considerably regarding 
their characteristics like transmission vector or pathogenicity [88]. Neuroinvasiveness is 
much lower in Siberian subtypes compared to Far-Eastern strains like Sofijn [100,101]. 
Therefore case fatality rates range substantially between groups. Whereas Far-Eastern 
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strains show a fatal outcome in 20-40% of the cases, Siberian and European subtypes are 
less virulent with 7-8% and >2% fatality rates respectively [96].  
 
Langat virus as a model for TBEV 
 
The TBEV complex also includes virus strains that cluster close to these three subgroups 
but are considered as independent species [95][102][103]. One example is naturally 
attenuated LGTV [104]. This strain was originally isolated in Malaysia and shares 82-88% 
homology to the strains of the TBEV group [105]. Therefore strain TP21 was originally 
considered for different vaccination approaches [106,107]. Good neutralizing antibody 
responses especially against the conserved E Protein have made LGTV a promising 
candidate. Since some volunteers that received the active virus or the inactivated vaccine 
developed meningoencephalitis vaccination with TP21, this approach was aborted 
[88][108]. The LGTV strain TP21 still exhibits neurovirulent properties in rodents, 
especially in immune deficient animals such as severe combined immunodeficiency 
(SCID)-/- and IFNAR-/- mice and can therefore be used to mimic neurotropic TBEV 
infections [20][88][109–111].  
Coupled with its relative harmlessness to humans under natural conditions, LGTV is used 
as experimental model for TBEV which can be handled under biosafety level 2 (BSL2) 
conditions [88]. In contrast, experimental work with regular TBEV strains is restricted to 
laboratory conditions at least on a BSL3 level [112].  
 
Virus structure 
 
Viruses of the TBEV group are positive charged, ssRNA viruses with an approximate size 
of 11 kilo base pairs [88][109]. A single open reading frame (ORF) encodes for a 
polyprotein that is cleaved into 3 structural (C, E, M) and 7 non-structural proteins (NS1, 
NS2A, NS2B, NS3, NS4A, NS4B, NS5) [88]. The outer shell structure of the virion 
consists of the capsid protein (C), additionally to the TBEV E Protein, that forms the 
envelope [88]. The E Protein is a glycoprotein that interacts with receptors, mediates cell 
entry and can protect the virions from nucleases [88]. Nevertheless, the envelope protein 
can also elicit immune responses by the host [88]. The membrane protein (M) is first 
enclosed in the virion and only cleaved from a preM to the mature M protein when the 
virus particle leaves the host cell [88]. The TBEV virion, with a diameter of 50 nm also 
contains nucleic acids that encode for proteins with different functionalities [88]. NS5 is the 
largest and most conserved non-structural protein with a methyltransferase activity as well 
as an RNA polymerase function. It associates with the serinprotease NS3 to a virus 
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replication complex [88]. NS1 and NS2A fixate this complex to the membrane, whereas 
NS2B is considered to be a Co-factor for NS3. NS4 then helps to orientate the polyprotein 
in the host cell membrane [reviewed 23]. 
 
Fig.2: Basic structure of a Flavivirus. Langat virus shares the basal structure of all Flaviviridae. 
The Nucleocapsid contains non-structural proteins 1-5 (NS1-5) which are surrounded by the 
Capsid (C). The particle is organized as icosahedral spheric structure. Envelope (E) and 
Membrane (M) proteins are anchored in the lipid bilayer and detectable by the immune system. 
Figure was modified by L. Zegenhagen [113].  
 
1.2.4. Infection with viruses of the TBEV group   
 
Viruses of the TBEV group are mostly transmitted by tick bite of Ixodes ricinus, but few 
cases are reported where the virus was incorporated by infected goat milk. Ticks favor a 
broad spectrum of vectors like rodents, deer, sheep, cows, moose but also humans 
[84][114]. In consent with a tick bite as transmission route, migrating monocytes and 
macrophages of the skin are possible target cells. These cells are known to be vehicles 
for systemic virus spread which is a common mechanism shown for other viruses [115–
117]. TBEV and LGTV can infect a broad range of immune cells like B cells, neutrophils 
and DCs, additionally to monocytes and macrophages [20][118]. However, the cell type 
that is most susceptible to LGTV infection are neurons [20][119,120]. LGTV is a 
neurotropic and neuroinvasive virus but the mechanism by which the virus enters the CNS 
and therefore gains access to the highly susceptible neuronal tissue is still unclear. Since 
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immune cells can be infected, it is possible that the virus enters the brain via the ´Trojan 
horse mechanism´ [20]. On the other hand, a brief viremia that was shown for other 
arboviruses might be sufficient for the virus to enter the CNS [121]. Since neurons are so 
susceptible to LGTV infection, the travelling of the virus via peripheral nerves like sensory 
olfactory neurons can also not be excluded [20]. Other flaviviruses like WNV have been 
shown to use several routes to enter the protected site of the CNS [122–124]. The virus 
induced for instance a high production of inflammatory cytokines that leads to a 
breakdown of the blood brain barrier (BBB) [122]. In contrast, in LGTV infection it was 
shown recently, that the virus can be detected in the brain already before the BBB is 
breached [20]. In this context, defects in recognition in LGTV like the absence of TLR7 
have been linked with enhanced viral replication and increased CNS infection in mice in 
vivo [125]. Mutations in the TLR3 gene have been associated with more severe TBEV 
disease in humans [126]. 
Once the virus reached the brain, different neuropathological effects can be observed, 
including perivascular cuffing and necrotic or degenerating cells in different brain regions 
[127]. This also includes infiltration of immune cells into the CNS, independent of the viral 
strain that was used, since it was observed for LGTV and Far Eastern strain Oshima [20] 
[127]. The effect in mice and humans is at least partly mediated by cytokines and cytokine 
receptors [128,129]. Inflammatory or anti-inflammatory cytokines have been shown to 
affect immune responses in the brain [127]. Cytokines like chemokine (C-C motif) ligand-4 
(CCL-4), CCL-5, chemokine (C-X-C motif) ligand (CXCL-9) and CXCL-10 are upregulated 
in LGTV infection [127]. Tumor necrosis factor-alpha (TNF-α) and C-C chemokine 
receptor type 5  (CCr5) were even employable to distinguish dying animals from survivors 
[127,128].   
Infiltrating cells differ in their potential role upon infection [128]. T cells have a protective 
function in TBEV infection whereas increased infiltration of neutrophils was associated 
with enhanced apoptosis in the CNS [128]. Neurons seem to be the key player in this 
situation [20][126][130]. Whereas Vero cells and Neurons are both susceptible to LGTV 
clone 636, only Neuro-2a cells showed a clear upregulation of cell death related genes 
and apoptosis [131]. In this context it is interesting to note, that TBEV replicates especially 
in neuronal dendrites. Abnormal swelling of neurites, membrane reorganization to elliptical 
structures and condensation of neuronal cytoplasma has been determined upon infection 
and this might also cause enhanced cell death [119]. This explains to some extent 
neurological symptoms and sequelae observed in patients [88].  
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1.2.5. Interference of TBEV and LGTV with the Innate Immune system 
 
Many flaviviruses are known to interact and interfere with the immune response to escape 
innate recognition. TBEV is no exception and multiple strategies have been uncovered 
about how TBEV is able to circumvent or delay IFN induction. By hiding in vesicles of the 
endoplasmatic reticulum (ER), TBEV strains like Neudoerfl, Hypr and Absetterov are able 
to hide early replication from cytosolic sensors and therefore allow the virus a head start 
[132]. However, spillover from the replication products can be detected later in the cytosol 
by RIG-I in an IPS-1 dependent manner and leads to the induction of a delayed type I IFN 
induction by IRF-3 [132,133]. Downstream signaling of induced and secreted IFN that is 
bound by IFNAR is then impaired by TBEV NS5 protein. NS5 of LGTV binds to prolidase, 
a cytosolic dipeptidase responsible for the localization and maturation of IFNAR1 to the 
cellular membrane [134]. This limitation of receptor availability leads to a reduced sensing 
of initially secreted type I IFN [134]. Studies also implemented a direct interaction of LGTV 
NS5 with IFNAR2 which leads to reduced pStat translocation to the nucleus [135]. 
Similarly, NS5 of Hypr was shown to locate to the host cell membrane in a complex with 
human host protein scribble (hScrib), which led to impaired Jak/Stat pathway activation 
[136]. As a counter measure, host factor tripartite motif 79 alpha (TRIM79α) has been 
shown to selectively degrade NS5 of TBEV [137].  
Nevertheless, even diminished levels of IFN can effectively induce antiviral factors. 
Therefore TBEV also counteracts several ISGs. It was shown that TBEV impaired DC 
maturation by the inhibition of IRF-1 translocation to the nucleus as well as the 
interference with IL-12 production. This was not only observed for attenuated LGTV but 
also for the more virulent TBEV strain Sofjin [138]. Thus, TBEV interferes with all parts of 
the type I IFN induction pathway and by this diminishes antiviral responses by the host.  
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1.3. Aim of the Thesis 
 
Emerging viruses associated to the genus Flavivirus have attracted a lot of attention in 
recent years [78–80]. Vaccination strategies, treatment options and prevention measures 
against arthropod vectors are often limited and therefore the interest in new therapeutic 
options is high [2][81]. In this context, a specific focus has been placed on innate immune 
responses. Viruses counteract very different parts of the initial defence, especially the 
induction and amplification of type I IFNs [132][134].  
Here, the TBEV strain LGTV was used as a model to study parts of the type I IFN 
signalling pathway in more detail. TBEV is an emerging pathogen on the northern 
hemisphere and even though vaccination strategies have been successful, risk factors for 
complications in neuropathology and neuroinvasiveness are still mostly unknown [78]. It 
was shown, that the loss of IFN-β is not critical for the survival of LGTV infection in mice 
[20]. However, the absence of a type I IFN response in IFNAR knock outs led to an onset 
of severe neurological symptoms similar to complications in humans, such as encephalitis 
and meningitis [20].  
Since the loss of different signalling components led to such diverse disease outcomes in 
vivo, the function of further key molecules that are involved in this pathway was of interest. 
Therefore, early mediators of type I IFN induction and factors involved in signal 
amplification were analysed in a mouse model. The aim was to characterize the impact of 
deficits in the IFN pathway on type I IFN induction in the periphery to identify possible 
protective factors.  
Since LGTV is a neurotropic virus, a specific focus of this work was also laid on infection 
mediated effects on the CNS in the absence of key factors of the IFN response. Very few 
information are available about the role of IPS-1, IRF-3 and IRF-7 in the brain, especially 
associated with TBEV or LGTV infection. Alterations in local immune responses in the 
absence of these factors were addressed and the type I IFN response of specific brain 
resident cells upon infection was characterized in more detail.   
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2. Results 
 
2.1. Type I IFN signalling in Langat virus infection  
 
The induction and maintenance of type I IFNs can be mediated by different signalling 
pathways [20][37]. This depends on the cellular location and the specific PRR that senses 
the virus [22][37]. Associated to the activated receptor the signal is transferred to specific 
adaptor molecules and further regulatory factors, which will initiate and enhance type I IFN 
signalling [26][37].  
 
2.1.1. Significance of TLRs and RLRs in LGTV infection 
 
Especially TLRs and RLRs have been shown to play an important role in the recognition 
of ssRNA viruses [37][139]. TLR7, TLR9 and TLR3 are bound to the endosomal 
membrane and transmit their signal via the adaptor molecule Myd88, or, in case of TLR3, 
TRIF [37].To test if TLRs or RLRs are important for the survival of LGTV infection, mice 
deficient for Myd88 and TRIF were infected and the survival analysed. Additionally the 
role of the RLRs RIG-I and MDA-5 were tested, which signal via the adapter molecule 
IPS-1 [25]. Genetically modified C57BL/6 mice deficient for Myd88, TRIF and IPS-1 were 
systemically infected by intraperitoneal LGTV injection (Fig.3).  
 
 
Fig.3: Role of RLR and TLR adaptor molecules Myd88, TRIF and IPS-1 in LGTV infection. 
Mice (n =5) deficient for IPS-1, Myd88 or TRIF and WT were infected intra peritoneally with 1x104 
FFU LGTV and monitored for survival. Statistical analysis was performed with Mantel Cox test, *** 
p˂0.0001.  
 
Most WT animals survive LGTV infection without any clinical symptoms. In contrast, mice 
defective for IPS-1 succumbed rapidly to infection after 7-9 days post infection (dpi) and 
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showed weight loss, hunchback, eye infections, fur ruffling and lethargy. In the absence of 
Myd88 all mice died within 12-17 dpi showing the same symptoms like IPS-1 animals. 
Like WT mice, TRIF-/- mice survive the infection with minor to no disease symptoms. This 
indicates that RIG-I and MDA-5 are important in the early phase, whereas the protective 
role of Myd88 dependent TLR7 and TLR9 is needed later during systemic LGTV infection. 
In addition, TRIF and therefore TLR3 signalling are dispensable for survival.   
To determine if TRIF, Myd88 and IPS-1 have potentially synergistic effects, Myd88-/-IPS-1-
/-
, Myd88-/-TRIF-/- and Myd88-/-IPS-1-/-TRIF-/- mice were infected systemically by 
intraperitoneal LGTV infection and monitored for survival.  
 
Fig.4: Synergistic effects of TLR and RLR adaptor molecules in LGTV infection. Myd88-/-IPS-
1-/- (n=11), Myd88-/-TRIF-/- (n=5) and Myd88-/-IPS-1-/-TRIF-/- (n=5) mice were infected i.p. with 1x104 
FFU LGTV. Survival was monitored and statistical analysis was performed with Mantel Cox test, *** 
p˂0.0001.  
 
Myd88-/-TRIF-/- mice died with a similar kinetic like Myd88-/- animals which underlines the 
negligible role of TRIF for LGTV infection in mice. Myd88-/-IPS-1-/- and Myd88-/-IPS-1-/-
TRIF-/- mice showed a comparable kinetic in the survival curve like IPS-1-/- mice, 
suggesting that IPS-1 is important to control initial LGTV infection. Taken together, this 
indicates a distinct time line for the activation of RIG-I and TLR pathways upon LGTV 
infection.  
 
2.1.2. Implications of distinct IRFs on the survival of LGTV infections 
 
IRFs are the main regulatory proteins in the type I IFN response and are known to be 
crucial for the survival of many different viral infections [31][71]. IRF-3 is responsible for 
early IFN induction, whereas IRF-7 has to be induced in most cell types and mediates 
signal amplification of the type I IFN response [69]. To elucidate distinct roles of different 
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IRFs in LGTV infection knock out animals were inoculated intraperitoneally with the virus. 
The survival analysis of IRF-3, IRF-7 and IRF-5 deficient animals is shown below (Fig.5) 
  
Fig.5: The influence of IRFs on the survival of LGTV infection. Survival analysis of WT (n=15), 
IRF-3-/- (n=15), IRF-5-/- (n=13) and IRF-7-/- (n=10) mice infected i.p. with 1x104 FFU LGTV. Data 
represent at least two independent experiments. Animals were monitored 21 days for survival. 
Statistical analysis was performed with Mantel Cox test.  
 
All IRF-3-/- and IRF-7-/- mice survive systemic infections with LGTV, whereas 
approximately 40% of the IRF-5-/- animals succumb to infection, with symptoms such as 
hunchback, lethargy and weight loss. This shows that IRF-5 plays a protective role in 
LGTV infection, whereas IRF-3 and IRF-7 are not essential for overall survival. However, 
mice were monitored for disease symptoms and weight loss and differences between WT, 
IRF-3-/- and IRF-7-/- animals can be detected during the course of the infection (Fig.6). 
 
Fig.6: Weight loss of IRF deficient animals infected with LGTV. WT, IRF-3-/- and IRF-7-/- mice 
were infected as before. Weight loss was determined daily until 15 dpi, calculated to the weight of 
the uninfected animal and represented in (%). Statistical analysis was performed by 1way ANOVA, 
*** p˂0.0001. Statistical error is depicted as standard error of mean (SEM).  
 
IRF-7-/- animals show a significant weight loss around 7-8 dpi in contrast to WT and IRF-3-
/-
 mice. Interestingly, none of these mice show any other disease symptoms, like lethargy, 
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hunchback or fur ruffling. This data indicates that even though animals present as overall 
healthy, infection by LGTV affects IRF-7 deficient mice. 
 
2.1.3. Type I IFN induction by LGTV in the absence of IRFs 
 
The loss of type I IFN signaling components often impacts systemic responses to viral 
infections. IFNAR-/- animals for instance show higher IFN levels in serum of WNV infected 
animals [31].  
Differences in systemic type I IFN responses in the absence of these IRFs have been 
noted in various infections [31][71]. In some cases the loss of IRF-3 and IRF-7 has no 
impact on serum levels at all, whereas decreased IFN serum levels have been noted in 
viral infections [29][31][54][71]. We therefore analysed serum of infected animals for the 
systemic type I IFN response upon LGTV infection (Fig.7).  
 
Fig.7: Loss of IRF-7 results in reduced systemic type I IFN responses. Blood was isolated 
from WT, IRF-3-/- and IRF-7-/- mice (n=5) 0, 2, 4, 7 and 9 dpi. Inactivated serum was analysed for 
type I IFN by a luciferase based bioassay. Type I IFN was calculated based on a standard curve 
and is depicted as Units IFN per ml. Statistical analysis was performed by 1way ANOVA. Statistical 
error is shown as standard error of mean (SEM). 
 
WT and IRF-3-/- animals show a systemic type I IFN response on 2 dpi. In contrast, the 
loss of IRF-7 abolishes type I IFN production in serum upon infection.  These data are 
comparable with that shown in WNV infections, which also belongs to the flavivirus family 
[54].  
 
2.1.4. Local type I IFN production in the periphery despite defects in IRFs 
 
Type I IFN is often produced locally. To detect organ and region specific type I IFN 
responses, a luciferase-based IFN-reporter mouse strain (IFN-β+/∆luc) was used. The 
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luciferase gene is expressed under the control of the IFN-β promotor. The heterogeneity 
of the gene locus ensures the production of IFN-β upon infection and allows simultaneous 
quantification of luciferin conversion by the equally induced luciferase [140]. Animals were 
infected with LGTV and IFN-β expression was quantified in several organs and results for 
spleen (Fig.8A), thymus (Fig.8B) and lung (Fig.8C) are shown below.  
 
Fig.8: Local IFN-β induction in LGTV infected reporter mice. IFN-β+/∆Luc, IFN-β+/∆Luc IRF-3-/- and 
IFN-β+/∆Luc IRF-7-/-  mice (n≥5) were infected i.p. as described and spleen (A), thymus (B) and lung 
(C) were isolated 0, 2, 4 and 7 dpi for quantification of luciferase expression. Luciferase level are 
shown as Relative light units (RLU) per ml and were normalized to 1 g  tissue. Statistical analysis 
was performed by 1way ANOVA, *** p˂0.0001. Statistical error is shown as standard error of mean 
(SEM).   
 
Type I IFN is induced in spleen and lung but not in the thymus of WT IFN-β+/∆luc animals at 
2 or 4 dpi. Even lower IFN level were detected in IFN-β+/∆luc IRF-3-/- animals. However, 
despite the absence of the positive feedback loop for IFN which is normally initiated by 
IRF-7, these animals were able to induce high local IFN-β expression levels. Spleens of 
IFN-β+/∆luc IRF-7-/- animals show comparable IFN-β level to IFN-β+/∆luc. Interestingly, in 
thymus and lung the IFN-β response was increased to a later time point but significantly 
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higher than in IFN-β+/∆luc mice. Overall lung showed here the lowest induction of type I 
IFNs.  
Even though type I IFN in serum is reduced in LGTV infection, type I IFN can be induced 
locally even in the absence of IRF-7. Secondary lymphoid organs like spleen behave like 
WT, whereas primary lymphoid tissues like the thymus only show an IFN response in the 
IRF-7 knock out. To determine the behaviour of other secondary lymphoid organs, the 
type I IFN response was evaluated in lymph nodes and nasal associated lymphoid tissues 
(Nalt)  (Fig. 9). 
 
Fig.9: Induction of IFN-β promotor in secondary lymphoid tissues in the absence of IRFs. 
Different lymphoid tissues were isolated from intraperitoneally with LGTV infected IFN-β+/∆Luc, IFN-
β
+/∆Luc
 IRF-3-/- and IFN-β+/∆Luc IRF-7-/- mice (n≥5) at 0, 2, 4 and 7 dpi. Luciferase expression of 
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mesenteric (A), inguinal (B), axial (C), brachial (D) and superficial (E) lymph nodes (LN) as well as 
nasal associated lymphoid tissue (Nalt) were quantified by bioassay and determined as RLU/ml. 
Statistical analysis was performed by 1way ANOVA, *** p˂0.0001. Statistical error is shown as 
standard error of mean (SEM). 
 
IFN-β was induced in lymph nodes of different origin at 2-4 dpi. The strength of the 
luciferase signal is comparable between mesenterial, inguinal, axial and brachial lymph 
nodes (A-D) in IFN-β+/∆luc mice. The signal was highest in the superficial lymph nodes (E) 
found in the environment of the salivary glands and lowest in lymphoid tissue of the snout 
and axial lymph nodes (C, F). This shows that intraperitoneally infected animals respond 
to the virus in a systemic manner. The response from IFN-β+/∆luc IRF-3-/- animals was 
slightly lower but else comparable to IFN-β+/∆luc mice.   
IFN-β promotor coupled luciferase induction was again much higher in the absence of 
IRF-7, compared to IFN-β+/∆luc and IFN-β+/∆luc IRF-3-/- animals (A-F). The induction in IFN-
β+/∆luc IRF-7-/- peaked around 4 dpi and decreased again to 7 dpi. As seen in superficial 
lymph nodes (E), the induction of type I IFN was realized earlier in infection compared to 
delayed induction of IFN-β+/∆luc IRF-7-/- tissues. This data shows that IFN-β expression is 
induced upon LGTV infection in an IRF-7 independent manner. This is in contrast to 
further observations during viral infection with other viruses. For this reason the 
significance of LGTV infection on peripheral organs was analysed in more detail. 
 
2.2. IRF dependent impact of systemic LGTV infection on the periphery  
 
Deficits in the type I IFN response have been associated with elevated virus replication in 
peripheral organs and therefore higher viral loads [20]. To validate if these changes can 
be seen in the LGTV infection model of IRF-3-/- and IRF-7-/- mice as well, different aspects 
of peripheral infection processes were dissected.  
 
2.2.1. Morphological changes in lymphoid organs in the absence of IRFs 
   
LGTV and TBEV can cause different macroscopic changes in peripheral organs upon 
infection. Light patches on the liver have been observed and can be associated with liver 
damage. Parts of the intestinal tract were affected. Icteric intestines, expanded guts 
probably due to intestinal congestion and hemorrhaging in the small intestine and gall 
bladder are visible in highly infected animals (observations of L.Zegenhagen, S.Schreier). 
Therefore, WT, IRF-3-/- and IRF-7-/- animals were analysed thoroughly for tissue 
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abnormalities. Here, isolated lymph nodes and spleens from different time points during 
the infection are shown (Fig. 10 and Fig. 11).  
   
Fig.10: Size gain of spleens and lymph nodes in LGTV infected animals. Inguinal (top) and 
brachial (bottom) lymph nodes (A) as well as spleen (B) from uninfected and systemically with 1x 
104 FFU LGTV infected WT and IRF-7-/- animals were isolated at 0, 7, 9 and 15 dpi (A). For each 
time point and genotype two representative mice are shown. Scale bar is indicated (1cm).  
 
Lymph node swelling and elevated spleen size were observed in acutely infected animals 
as a phenomenon that was independent of the genotype. These alterations can occur in 
acute immune responses and are caused by leukocytes proliferation and cell recruitment 
[141,142].  
 
Fig.11: IRF dependent alterations in spleen dimensions upon LGTV infection. Spleens of i.p. 
with LGTV infected WT, IRF-3-/- and IRF-7-/- animals were analysed for alterations in weight (n ≥15) 
(A) and in WT and IRF-7-/- spleens for differences in length (n ≥3) (B). Statistical analysis was 
performed with 1way ANOVA, *** p˂0.0001 (A) and t test (B), *** p˂0.0001. Statistical error is 
shown as standard error of mean (SEM). 
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An increase in spleen weight (A) and length (B) caused by systemic LGTV infection was 
seen in WT animals, 7 dpi. A similar and significantly elevated spleen weight was also 
noted for IRF-3-/- and IRF-7-/- mice upon infection. The size of the spleen, represented 
here as spleen length, was enhanced in WT and IRF-7 animals in a similar manner and 
decreased in the later course of infection, as also seen in Fig.10 and 11.  
Animals show a clear splenomegaly and lymph node hyperplasia along with enhanced 
type I IFN responses (Fig.8 and 9) which indicates an activation of the immune system 
upon systemic LGTV infection that affects different peripheral organs.  
 
Macroscopic changes often result in the alteration of microscopic structures. To determine 
if the structural integrity of spleen was still intact and if there are changes in the number of 
immune cells harboured by the organ, spleens were histologically analysed.  
Spleens function as filter organs and the parenchyma consists of white and red pulp. 
Whereas red pulp takes mainly part in the blood filtration, lymphocytes of the white pulp 
are able to recognize potential pathogen associated antigens that may be present by 
peripheral blood cells [143]. The white pulp appears as follicular structures which are 
additionally enclosed by a marginal zone and further surrounded by red pulp. These 
structures contain different lymphocytes populations. Upon infection this framework can 
disperse due to massive cell proliferation and cell migration. Therefore spleen microscopy 
was evaluated for WT, IRF-3-/- and IRF-7-/-. Spleens of highly infected IFNAR-/- animals 
were used as controls (Fig.12).  
 
Fig.12: Impact of LGTV infection on spleen integrity. WT, IRF-3-/-, IRF-7-/- and IFNAR-/- spleens 
of uninfected and systemically LGTV infected animals were analysed for LGTV induced structural 
alterations. Organs were fixed and sectioned by cryotome into 30 µm slices. Cell nuclei were 
stained with DAPI. A representative white pulp (WP), marginal zone (MZ) and red pulp (RP) are 
indicated. Pictures were taken at 20x magnification and a scale bar is indicated.  
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The framework of WT, IRF-3-/- and IRF-7-/- spleens was intact independent of LGTV 
infection. In contrast, spleen integrity of infected IFNAR-/- animals was dissolved and white 
pulp, marginal zones and red pulp areas were no longer distinguishable. 
Even though no differences in the overall organ structure were observable, in the absence 
of IRFs, variations in the location of different cell populations might occur. White pulp 
follicles contain B cells, T cells as well as macrophages, DCs and reticular cells [143]. 
These cells are arranged in specific zones and changes can be detected in differentiated 
immune responses [143–145]. Therefore we analysed splenic follicles for the presence 
and dissemination of immune cells. Cell nuclei were additionally stained to allow structural 
orientation (Fig. 13).  
 
Fig.13: Histological analysis of spleen integrity upon LGTV infection. Spleens were isolated 
from systemically LGTV infected animals (n=3). After fixation, organs were embedded and 30 µm 
thick spleen slides obtained by cryotome sectioning. Spleen sections were stained for surface 
antigens B220 (A, B cells and DCs), F4/80 (B, macrophages) and CD8a (C, cytotoxic T cells and 
DCs). Nuclei were stained with DAPI. Pictures were taken at 20x magnification and scale bar is 
indicated (50 µm).  
  
High numbers of B220 positive cells (A) could be detected, especially inside of the white 
pulp follicles of all analysed spleens. F4/80+ macrophages (B) were mainly observed in the 
marginal zone of lymphoid follicles. The same was true for CD8+ cytotoxic T cells (C). 
Overall, no differences in microscopic spleen structure and immune cell localisation were 
determined in infected and uninfected animals in the absence of IRFs.  
 
2.2.2. The impact of IRFs on immune cell populations in infected spleens 
 
Associated to the splenomegaly, alterations can be expected in the number of spleen cells 
and the composition of different leukocyte populations. Therefore myeloid splenocytes 
that may play a role in innate immune defences were analysed by flow cytometry (Fig.14).    
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Fig.14: Differences in myeloid splenocyte populations in the absence of IRFs in LGTV 
infection. Splenocytes were obtained from spleens of systemically with 1x 104 FFU LGTV infected 
(7dpi) and uninfected WT, IRF-3-/- and IRF-7-/- animals (n=5). Splenocytes were characterized 
according to their surface marker expression as monocytes, macrophages (MØ) and granulocytes 
(GC) (A). Cells were identified as CD11b+Ly6G-Ly-6C+ monocytes (B), CD11b+Ly6G-Ly-6C- 
macrophages (C) and CD11b+Ly6G+Ly-6C+ granulocytes (D). Splenocytes were counted and cell 
populations were calculated to the total number of spleen cells. Statistical analysis was performed 
by 1way ANOVA, *** p˂0.0001. The statistical error is shown as standard error of mean (SEM). 
  
The overall number of monocytes, macrophages and granulocytes increases due to LGTV 
infection in all genotypes (B-D). Significantly higher numbers of granulocytes and 
macrophages but nor monocytes were found in spleens of infected IRF-7-/- animals (C, D). 
These cells are described as effector cells that can be mobilized from spleen in high 
numbers to inflammatory sites [146,147]. This indicates elevated inflammatory processes 
upon LGTV infection in IRF-7-/- animals compared to WT and IRF-3-/- mice. Of note, IRF-7 
has been described as differentiation factor for monocytes in vitro [74]. No reduced 
macrophage numbers have been detected in our mouse model. However, a reduction in 
phagocytic activity was not analysed in these cells and can therefore not been excluded 
[74].   
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Other phagocytic cells and cells related to the adaptive immune response also play a role 
in inflammatory processes [9][148]. Therefore the frequency of NK cells, T cells and B 
cells in spleens upon LGTV infection was analysed (Fig.15).   
 
 
 Fig.15: Alterations in splenocyte frequencies upon LGTV infection. Spleens were isolated 
from systemically LGTV infected (7dpi) and uninfected WT, IRF-3-/- and IRF-7-/- mice (n=5). 
Splenocytes were analysed according to surface antigens (A, B, C) and quantified as CD11b-CD4-
CD8a+ T cells (D), CD11b-CD8-CD4+ T cells (E), Nkp45+ cells (F) and CD11b-CD4-CD8a-B220+ B 
cells (G). Cells were calculated to the total number of splenocytes. Statistical analysis was done 
with 1way ANOVA, *** p˂0.0001 and statistical error is shown as standard error of mean (SEM). 
 
Similar to monocytes, macrophages and granulocytes, numbers of T cells and NK cells 
expand due to infection with LGTV (D-F). Still, this is only significant for CD8+ T cells in 
IRF-7-/- animals (D). In contrast, B cell numbers are nearly unaffected by LGTV infection 
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(G). In summary, it can be concluded that the elevated spleen weight is attributable to an 
expansion of different immune cell populations upon infection. Still, the exact role of 
individual cell subsets in LGTV infection is not yet defined even though it has been 
described that different hematopoietic subsets can be infected by LGTV [20].   
To determine if cells of the spleen are overall more susceptible to LGTV infection in the 
absence of IRF-3 and IRF-7, viral loads were determined (Fig.16).  
 
Fig.16: IRF-7 exhibits a protective function in spleen. Spleens were isolated from uninfected 
and systemically with LGTV infected WT, IRF-3-/- and IRF-7-/- animals (n=5). Viral RNA was 
determined by qRT-PCR detecting a specific NS3 sequence. CP values were normalized to the 
housekeeping gene β-Actin and relative expression calculated to uninfected WT samples. 
Statistical results were obtained by Mann-Whitney test, *** p˂0.0001.  
 
Viral loads were enhanced in WT samples of spleen at 2 dpi but decrease in the course of 
infection. Viral titers in spleens of IRF-3-/- animals behave similarly. The virus load in IRF-
7-/- splenocytes was already significantly higher at 2 dpi compared to WT, indicating that 
these cells were more susceptible to LGTV infection. In contrast to WT and IRF-3-/-, viral 
titers do not decrease in IRF-7-/- spleens in the course of infection. Therefore restriction of 
viral replication and viral clearance were impaired in the absence of IRF-7.  
 
2.2.3. IRFs protect hematopoietic cells from LGTV infection 
  
Macrophages, B cells and DCs can be infected by LGTV [20] and splenocytes show 
elevated viral level (Fig.16). Therefore the susceptibility of specific hematopoietic cells to 
LGTV in the absence of IRF-3 and IRF-7 was of interest. Since the specific focus lies here 
on defects of the type I IFN system, the aim was to elucidate the ability of IFN producing 
cells (IPCs) to resist LGTV infection. Therefore cells were isolated and differentiated from 
the bone marrow of WT, IRF-3-/- and IRF-7-/- animals and differentiated toward different 
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IPC populations. Bone marrow derived macrophages (BMDMs) and different DC 
populations namely pDCs and mDCs were used for infection experiments (Fig.17).  
 
Fig.17: IRF-3 protects BMDCs from LGTV infection in vitro. Bone marrow derived cells were 
differentiated to pDCs, n≥5 (A, D), mDCs, n≥10 (B,E) and macrophages, n≥8 (C,E). Cells were 
infected with LGTV, multiplicity of infection (MOI) 0.5. Cells were fixed and stained with DAPI and 
viral anti-NS3 antibody 72 hpi. Displayed are uninfected (Ctrl.) and infected cells. Pictures were 
taken at 40x magnification and a scale bar is indicated (50 µm). Infected cells were counted and 
calculated to DAPI positive cells as (%). Statistical analysis was done with 1way ANOVA, *** 
p˂0.0001. The statistical error is shown as standard error of mean (SEM). 
  
WT cells showed only a very low infection rate from 0.5 to 1%, which indicates a low 
susceptibility of these cells to LGTV infection. In contrast, IRF-3-/- cells showed a relatively 
high infection rate in vitro. IRF-3-/- mDCs and macrophages are significantly higher 
infected than corresponding WT and IRF-7-/- cells. However, IRF-7-/- pDCs represent 
infection rates similar to IRF-3-/- pDCs at 72 hpi.  
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This elevated susceptibility of bone marrow derived IRF-3-/- cells clearly differs from in vivo 
data in spleen, where viral loads in IRF-7-/- splenocytes (Fig. 16) were increased 
compared to WT and IRF-3-/-. Therefore local antiviral factors might play a role in the in 
vivo protection of IRF-3-/- animals.  
 
2.2.4. The role of IRFs in the type I IFN production of hematopoietic cells during 
LGTV infection 
 
Especially pDCs but to some extent also macrophages have been shown to elicit type I 
IFN responses [71][149]. Since very few of the BMDCs were infected, these cells might be 
protected by the induction of IFN. To evaluate the capacity of these populations to induce 
protective immune responses in the absence of IRF-3 and IRF-7, we tested these cells for 
their ability to secrete type I IFN (Fig.18).  
 
Fig.18: Impaired Type I IFN responses in BMDCs in the absence of IRF-7. Differentiated WT, 
IRF-3-/- and IRF-7-/- BMDCs were infected with LGTV (MOI 0.5) and tested in a bioassay for their 
ability to induce type I IFN. Shown are pDCs, n≥11 (A), mDCs, n≥16 (B) and macrophages, n≥7 
(C). Supernatants of these cells were analysed 24, 48 and 72 hpi and uninfected cells used as 
controls. Type I IFN was quantified based on a standard curve. Shown are at least two 
independent experiments. Statistical analysis were performed with 1way ANOVA, *** p˂0.0001. 
Statistical error is shown as standard error of mean (SEM). 
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Overall, pDCs showed the highest induction of type I IFNs which is according to literature 
[71][150]. However, due to the constitutive expression of IRF-7, WT pDCs should be able 
to induce high amounts of type IFN much faster than other cells (A). Here, WT 
macrophages induce type I IFN earlier although in a lower and steadier manner (C). 
MDCs in contrast, induce relatively low amounts of type I IFN compared to macrophages 
and pDCs (B).  
In the absence of IRF-3, type I IFN can be induced comparable to the WT situation. 
However, the loss of IRF-7 leads to abolished IFN responses in pDCs and decreased type 
I IFN levels in macrophages and mDCs. This is again according to literature, since high 
type I IFN production is known to be crucially dependent on IRF-7 [71]. Nevertheless, this 
data does not explain IFN-β expression that was seen in lymphoid organs (Fig.8 and 9) in 
earlier experiments. In contrast published data to WNV infection reflects the situation 
represented by type I IFN levels that have been detected in serum of IRF-7-/- animals 
(Fig.7) [54].  
 
2.3. Specific functions of IRFs in neurotropic LGTV infection 
 
LGTV is a virus with neuroinvasive and neurovirulent properties [20]. Even though the 
initial infection often occurs in the periphery, the potential damaging effects by LGTV are 
mainly due to the infection of the CNS [151]. To date it is unknown how Langat virus 
enters the brain. Infected hematopoietic cells from spleen (Fig.16) might act as “Trojan 
horses” or transient viremia might play a role in CNS invasion. Once the virus enters the 
brain, several local and protective immune responses can be induced by brain resident or 
infiltrating immune cells [151]. In this context, the local impact of IRF deficiency on distinct 
brain resident cells and the overall immune response was characterized in the CNS. 
 
2.3.1. The influence of distinct IRFs on LGTV distribution in the CNS  
 
Low and transient viremia is a phenomenon known from other arboviral infections and 
might promote viral dissemination of the virus in the periphery and invasion to the CNS 
[121]. For this reason viral loads were determined in serum of IRF deficient animals upon 
peripheral LGTV infection (Fig.19).  
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Fig.19: The loss of IRF-7 leads to transient viremia in LGTV infection. Blood was isolated from 
systemically infected WT, IRF-3-/- and IRF-7-/- mice. Serum was tested for the presence of viral NS3 
by qRT-PCR at 2 and 4 dpi. CP values were normalized to β-Actin and the relative expression was 
calculated based on uninfected WT samples. Results are displayed as arbitrary units and the 
dotted line represents signal intensity of uninfected controls. Statistical results were obtained by 
Mann-Whitney test, *** p˂0.0001. 
 
Viral levels in serum of WT animals decreased slightly in the course of infection, similarly 
to LGTV quantities in serum of IRF-3-/- and IRF-7-/- animals. Significantly elevated levels of 
LGTV NS3 were observed in the serum of IRF-7-/- animals at 2 dpi which decreased to 4 
dpi. This indicates a transient viremia in IRF-7-/- animals.  
A viremia can lead to enhanced dissemination of the virus into peripheral organs but also 
into the CNS. Since LGTV is a neurotropic virus differences in the neuropathology of IRF-
7-/- animals was of specific interest and will be addressed in more detail.  
Due to the location, different regions of the CNS show varying access to the immune 
system and provide the pathogens with several access options. The olfactory bulb 
represents the smaller anterior part of the CNS whereas the cerebrum is a comparably 
huge region with multiple functions such as cognitive control, processing of sensory 
stimuli and storage of information. The cerebellum handles all motor functions and lies on 
the posterior axis of the brain. Below, the brain stem is located, which is accountable for 
vegetative functions such as breathing and descends into the spinal cord. Due to 
variations in their accessibility for the virus via peripheral neurons, breaches of the BBB or 
cerebrospinal fluid barrier (CSFB) or the “Trojan Horse” mechanism all regions were 
tested separately for viral loads (Fig.18). To characterize the local impact of IRF-3 and 
IRF-7 on LGTV infection in the brain, viral loads were determined in different brain regions 
(Fig.20). 
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Fig.20: IRF-7 suppresses LGTV infection in the CNS. WT, IRF-3-/- and IRF-7-/- mice were 
infected systemically with LGTV with 1x 104 FFU. Olfactory bulb (A), cerebrum (B), cerebellum (C) 
and brain stem (D) were analysed by q RT-PCR and relative expression of NS3 RNA was 
normalized to β-Actin and calculated to uninfected WT samples (dotted line). Results are indicated 
as arbitrary units (au). Statistical analysis was done by Mann-Whitney test, *** p˂0.0001. 
 
LGTV was detectable in all brain parts of WT animals and the signal was highest in the 
olfactory bulb (A) and lowest in brain stem (D). Viral amounts increased in the course of 
infection except for brain stem where viral signal remained very low (A-D). Enhanced viral 
replication was also seen in the olfactory bulb, cerebrum, cerebellum and brain stem of 
IRF-3-/- and IRF-7-/- brains from 4 dpi to 7 dpi. Whereas NS3 LGTV signals of IRF-3-/- mice 
were comparable to WT, the loss of IRF-7 led to higher viral signals in all brain parts. This 
suggests that IRF-7 acts as a restriction factor for viral replication in the brain.  
 
Not only different brain regions but also different structures of the CNS can be targeted by 
different viruses. This is due to local differences in the cellular composition of the brain as 
well as differentially regulated regional immune responses [152]. To elucidate if specific 
brain areas are particularly affected by the loss of IFN regulating factors such as IRF-3 
and IRF-7, histological stained sections of the brain were screened for the presence of 
viral E-protein (Fig.21).  
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Fig.21: LGTV is disseminated equally in specific brain structures in the absence of type I 
IFN signaling components. Brain of uninfected or i.p. with LGTV infected WT, IRF-3-/-and IRF-7-/- 
and mice (n≥3) were isolated 7dpi and stained for virus (E-Protein) and cell nuclei (DAPI). Shown 
are olfactory bulb (Olf. Bulb), cortex and hippocampus (Hipp.) and pictures were taken at 20x 
magnification and scale bar is indicated (200 µm). Representative pictures for at least three 
independent experiments. 
 
The virus was mainly detected in the olfactory bulb region of WT, IRF-3-/- and IRF-7-/- 
animals. Affected by LGTV was especially the glomerular cell layer which receives direct 
input from external sensory neurons. In the mitral cell layer and the granule cell layers of 
the olfactory system which are sequentially located, nearly no virus signal can be seen. 
Independent of the genotype, no reliable signals were detected in other representative 
brain regions such as cortex and hippocampus. Other specific brain structures for 
instance striatum, thalamus, midbrain, cerebellum and brain stem were checked but no 
virus signal was detected (data not shown). The RT-PCR represents therefore the more 
sensitive method for virus detection in this model.  
The olfactory bulb of WT animals shows a much lower viral signal than IRF-7-/- mice. 
Nearly no signals were detected in IRF-3-/- brains.  
IRF-7 was identified as a restriction factor of the type I IFN system that limits viral 
replication especially in the olfactory bulb region.  
 
2.3.2. Immune cell related alterations in infection due to defective type I IFN 
responses  
 
High viral replication in the CNS is often correlated with enhanced local inflammation. The 
associated production of pro-inflammatory cytokines then leads to the increased 
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recruitment of immune cells from the periphery. Cells such as CD8 T cells, macrophages 
and neutrophilic granulocytes invade the CNS upon infection [148][153,154]. These cells 
play a crucial role in the clearance of the infection but also in the induction of harmful 
neuropathology [154]. Therefore alterations in the invasion of immune cells into the CNS, 
in combination with a disturbed type I IFN response, were analyzed (Fig.21).  
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Fig.22: Impact of type I IFN deficiencies on immune cell infiltration into the CNS. Cells were 
isolated from brains of uninfected and systemically LGTV infected (7dpi) WT, IRF-3-/- and IRF-7-/- 
(n=5) mice by percoll gradient and cell numbers were determined. Cell populations were 
charcterized by surface marker expression as CD45hi infiltrating cells (A, B). Cells were further 
distinguished into CD45hiCD11c+ DCs (C), CD45hiCD11b-CD4-CD8+ T cells (D), CD45hiCD11b-CD8-
CD4+ T cells (E), CD45hiCD11b+Ly-6C-Ly-6G+ monocytes (F) and CD45hiCD11b+Ly-6C-Ly-6G- 
macrophages (G) and calculated to total cells per brain. Statistical analysis was performed by 1way 
ANOVA, *** p˂0.0001. Standard error of mean is depicted (SEM).  
 
Only low number of immune cells can be found in the CNS of uninfected animals of the 
different genotypes. However, peripheral virus infection with LGTV leads to the infiltration 
of  high numbers of different leukocytes into the CNS (A, B). Whereas in WT and IRF-3-/- 
only moderately enhanced cell counts were observed, IRF-7 shows a massive infiltration 
of leukocytes into the brain of infected animals 7dpi. Significantly elevated numbers of 
DCs (C), T cells (D, E) as well as monocytes (F) and macrophages (G) have been 
detected in the CNS of infected IRF-7-/- animals. This infiltration indicates a massive 
inflammatory impact on the brain of LGTVinfected IRF-7-/- animals.  
 
Microglia are counterparts of monocytes and macrophages in the CNS [155]. These 
sentinels exhibit a surveillance function, phagocyte cell debris in the CNS, produce growth 
factor for cell survival or attract macrophages from the periphery to the CNS [155]. The 
activation of these cells by inflammatory processes in the CNS often results in a 
phenotype switch associated with a changed expression pattern of surface molecules 
[155,156]. Therefore microglia were analyzed for their frequency and activation status 
(Fig.23).  
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Fig.23: Alterations in IRF deficient microglia in the infected CNS. CD45lo and CD45int, CD11b+ 
Microglia were isolated from brains of uninfected and systemically LGTV infected WT, IRF-3-/- and 
IRF-7-/- (n=5), 7dpi. (A) Total number of microglia from isolated brain cells. (B) Microglia activation 
was determined by CD11c staining. Histograms show an overlap of uninfected populations (dark 
grey) with infected (light grey) populations. Statistical analysis was performed by 1way ANOVA, *** 
p˂0.0001. Standard error of mean is depicted (SEM).   
 
LGTV infection in WT mice leads to an increase in microglia numbers whereas quantities 
are not changed in IRF-3 deficient mice. Interestingly, in IRF-7 deficient mice microglia 
number decreases, indicating a special role of IRF-7 in proliferation or cell death of 
microglia. Upon activation microglia increase expression of CD11c on the cell surface 
[156]. To determine changes in activation status of microglia we determined CD11c and 
CD45 expression of microglia. WT microglia did not show an increase in CD11c 
expression. However, CD11c expression on microglia of IRF-7-/- mice increases upon 
infection. This indicates that although the numbers of microglia decrease upon infection, 
these cells show an activated phenotype.  
 
Alterations in the activation profiles of immune cell populations are already known to 
mediate viral clearance but also neuropathological effects [122]. To evaluate if the 
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activation of immune cells is a general alteration in the neurotropic immune response of 
IRF-7-/- animals to LGTV, different infiltrating immune cell populations were analysed 
according to their activation profile by CD80+ expression (Fig.24).   
 
Fig.24: Activation profiles of infiltrating immune cells in the absence of IRFs. Monocytes (A), 
macrophages (B) and DCs (C) were isolated from systemically infected (7dpi) WT (n=5) and IRF-7-
/-
 (n=3) mice. Cells were characterized as CD80+CD11b+Ly-6C-Ly-6G+ monocytes (A), 
CD80+CD11b+Ly-6C-Ly-6G- macrophages (B) and CD80+CD11b+CD11c+ DCs (C) in % of the 
whole population. Statistical analysis was performed by 1way ANOVA, *** p˂0.0001. Standard 
error of mean is shown (SEM).   
 
No differences in the activation profile of monocytes were detected between WT and IRF-
7-/- (A). A significantly higher number of activated macrophages was found in the IRF-7-/- 
mice compared to WT (B).  
Interestingly, more activated DCs were found in WT controls compared to IRF-7-/- (C). 
This indicates that the absence of IRF-7-/- leads to a different activation pattern in 
infiltrating immune cells of the CNS during infection. It is not clear if these differences 
might be strong enough to have an impact on overall inflammatory processes or the 
efficiency of viral clearance in the CNS. 
 
Immune cell infiltration and activation is mediated by pro- and anti-inflammatory cytokines. 
To assess if viral replication induces pro-inflammatory cytokine TNF-α and the immune 
cell attractant CCL2, expression levels were determined by RT-PCR  (Fig.25) [17]. 
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Fig.25: Alterations in inflammatory cytokine levels in the CNS upon LGTV infection. Mice 
were systemically infected with 1x 104 FFU LGTV. Expression of the inflammatory cytokines TNF-α 
(A) and CCL2 (B) at 4 and 7 dpi were determined in the olfactory bulb of the brain by quantitative 
real time RT-PCR. Expression was normalized to β-Actin as housekeeping gene and relative 
expression determined based on uninfected WT samples. Statistical analysis was performed by 
1way ANOVA, *** p˂0.0001.  
 
Due to high viral levels in different brain parts (see Fig. 19 and 20), the olfactory bulb was 
chosen as a representative region to test alterations in different cytokine levels induced by 
virus infection. TNF-α (A) was clearly upregulated in the course of infection, independent 
of the genotype of the animals. However, in IRF-7-/- animals a significant increase was 
detected already on day 4 pi compared to WT and IRF-3-/-. The expression levels of TNF- 
α rose even further until 7 dpi. The same trend was observed for CCL2 expression (B). 
CCL2 expression increased during the infection in all animals but the loss of IRF-7 led to 
higher increased expression levels.  
This shows that a higher inflammatory response represented by high CCL2 and TNF-α 
expression levels can be seen in the CNS of WT and IRF-3 but especially IRF-7 deficient 
animals. This might be due to higher viral levels in IRF-7-/- animals (Fig.20), higher influx 
of immune cells into IRF-7-/- brains (see Fig. 22) or can be an intrinsic mechanism of the 
local loss of IRF-7 in the CNS. These differences have been detected in the olfactory bulb 
but differences in other brain regions are likely, since many cytokines exhibit long distance 
properties [157].  
 
Viral replication and cytokine mediated effects can cause enhanced cell death upon 
infection. This is especially critical in the mammalian CNS where most of the neuronal 
populations are irreplaceable by the adult host. We found increased viral replication, 
elevated TNF-α level and enhanced numbers of CD8+ T cells in the CNS of infected IRF-
7-/- animals. These components are known to influence inflammation associated 
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processes and cell death [158]. Therefore the aim was to determine if apoptosis is 
enhanced in the brain of IRF-7-/- animals compared to WT, IRF-3-/- and IPS-1-/- mice 
(Fig.26).  
 
Fig.26: The influence of type I IFN deficiencies on apoptotic processes in the CNS in viral 
infection. Brains of systemically infected WT, IRF-3-/-, IRF-7-/- and IPS-1-/- mice (7dpi) were 
analysed for active Caspase 3 (Asp 175+) positive cells. Nuclei of cells were stained for DAPI. (A) 
Displayed are representative 30 µm IHC sections of olfactory bulb, cortex, hippocampus and 
cerebellum. Magnification 40x and scale bar is indicated (50 µm). Caspase 3 positive cells were 
calculated for the OB to the number of DAPI positive cells in (%) of n≥5. Statistical analysis was 
performed by 1way ANOVA, *** p˂0.0001. Standard error of mean is shown (SEM).   
 
In different brain regions apoptotic cells could be detected for all genotypes upon infection 
with LGTV (A). Nearly no apoptotic cells were detected in uninfected animals (data not 
shown). In WT only few apoptotic cells could be observed in the olfactory bulb and none in 
other brain regions. The CNS of IRF-3-/- mice showed no apoptotic cells at all. In contrast, 
Caspase 3 positive cells were detected in all brain regions of IRF-7-/- and IPS-1-/- animals. 
Since the highest number of apoptotic cells was observed in the olfactory bulb differences 
were quantified in this region (B). The number of apoptotic cells in the olfactory bulb 
increased from 1 % in WT mice to approximately 3 % in IPS-1-/- animals. Only IPS-1-/- 
animals showed a significant increase of apoptotic cells in the CNS. Still, the overall 
number of apoptotic cells even in the brain of IPS-1-/- mice was comparably low and 
probably not sufficient to explain enhanced mortality in these animals. Therefore 
enhanced inflammatory responses do not contribute to Caspase 3 mediated cell death.  
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2.3.3. Cellular tropism in LGTV infection in the absence of IRFs 
 
LGTV and TBEV target especially neuronal cells in humans and mice [20][159]. However, 
the loss of type I IFN signalling components has often been shown to lead to altered 
tissue tropism upon infection [160,161]. For this reason the tissue tropism of LGTV for 
different brain resident cells was analysed in detail (Fig.27).  
Fig.27: Altered tropism of LGTV to brain resident cells in the absence of IRF-7. IHC of the 
olfactory bulb of systemically LGTV infected WT, IRF-3-/- and IRF-7-/- mice (n≥3). Neurons were 
identified as NeuN+ (A), astrocytes as GFAP+ (B) and microglia as IBA-1+ (C) cells and nuclei 
counterstained with DAPI. LGTV was detected by viral E-Protein. Pictures were taken at 40x 
magnification and scale bar is indicated (50 µm). White arrows indicate magnified infected and 
uninfected neurons, astrocytes and microglia at 0 and 7 dpi. The number of infected cells was 
quantified and normalized to DAPI+ cells. Data is shown for neurons (D), astrocytes (E) and 
microglia (F). Statistical analysis was done by 1way ANOVA, *** p˂0.0001. Standard error of mean 
is depicted (SEM).   
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The olfactory bulb was chosen as representative region for the analysis of infected brain 
resident cells. In the WT situation neurons, astrocytes and microglia can be infected in 
relatively low numbers. In contrast, the loss of IRF-7 led to a significant increase of 
infected brain resident cells compared to WT and IRF-3-/- (D-F). Neurons are highly 
infected by LGTV which is according to literature (D).  However, the neuronal marker 
NeuN failed to stain specifically periglomerular neurons of the glomerular cell layer that is 
mostly affected by LGTV infection. Therefore the number of infected neuronal cells is 
expected to be much higher than displayed here. Astrocytes that lack IRF-7 are also 
highly susceptible to LGTV whereas nearly no infected astrocytes can be detected in WT 
and IRF-3-/- animals (E). The number of infected microglia varies substantially between 
representative regions of the olfactory bulb and therefore no significant differences can be 
determined between different genotypes (F).  
Overall, a shift in the cellular tropism towards the infection of astrocytes was determined 
for IRF-7-/- deficient animals additionally to the infection of neurons. This implies a locally 
defined role of IRF-7 in the infection of brain resident cells and specifically in astrocytes. 
 
2.4. Local protective roles of IRFs in LGTV mediated CNS infection 
 
Systemic infections lead to broad immune responses that might overlay or mask organ 
specific local peculiarities [20]. For instance the massive influx of leukocytes into the CNS 
upon infection and their cytokine mediated side effects might counteract potential anti-
inflammatory responses that are elicited by neuroparenchymal cells themselves. To 
disassemble and evaluate specific LGTV mediated effects on cells of the CNS a local 
infection of brain cells and the analysis of specific resident cell types is needed. 
 
2.4.1. Local LGTV infection in the CNS of IRF deficient animals 
 
Even though it is assumed that LGTV enters the CNS after systemic infection, local and 
regional differences can be determined more easily by infections that are locally restricted. 
Intra cranial (i.c.) infections can provide more detailed information about brain intern 
restriction mechanisms and were therefore employed here, to determine differences in the 
susceptibility of different genotypes to LGTV infection (Fig. 28).  
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Fig.28: Impact of distinct IRFs on local LGTV infection. WT (n≥5), IRF-3-/- (n≥5) and IRF-7-/- 
(n≥9) mice were infected intra cranially with 100 FFU (A) or 10 (FFU) LGTV. Survival of these 
animals was monitored for 15 days after infection.   
 
In contrast to systemic infection (see Fig. 5) animals of all genotypes succumb rapidly to 
the local infection within 7 days post infection (A), even though the virus concentration 
was much lower compared to i.p. injection. This indicates a specific susceptibility of the 
CNS to LGTV infection. A ten times lower virus dose (B) rescued all WT animals, but only 
approximately 60 % of the IRF deficient animals. This data shows that IRF-3 and IRF-7 do 
have protective local roles in the CNS but this protection is clearly dependent on the viral 
burden. Here, no differences between IRF-3 and IRF-7 could be detected, which implies 
equally important roles in the restriction of initial viral replication in the CNS.  
 
2.4.2. Cell type specific roles of IRF-3 and IRF-7 in the CNS upon LGTV infection  
 
Brain resident cells play a specific role in the defence of invading pathogens. Neuronal 
cells, astrocytes and microglia have been shown to tightly regulate their 
immunomodulatory environment to reduce inflammation mediated damage to non- or slow 
proliferating cells [162,163]. However, these cells also take actively part in their own 
defence by the production of type I IFNs, antiviral factors and growth factors which 
promote their survival [164,165]. To determine the role of neurons, astrocytes and 
microglia, cells were tested in vitro for their susceptibility to LGTV and their ability to 
mount type I IFN responses in the absence of IRFs.  
Since neuronal cells were highly infected in the in vivo mouse model, we determined viral 
replication in primary neurons (Figure 29).  
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Fig.29: LGTV Infectivity and viral replication in neurons in the absence of IRF-7. Primary 
hippocampus derived neuronal cells from WT and IRF-7-/- animals were differentiated, cultured and 
infected with LGTV, MOI 0.001. (A) Cells were fixed and stained for viral antigen NS3 and nuclear 
DNA with DAPI (n≥5). Shown are representative pictures of neuronal cultures. Pictures were taken 
at magnification 40 x and scale bar is indicated (50 µm). (B) The number of infected cells was 
calculated to total DAPI positive cells in (%). (C) Infectious viral particles in the supernatants of 
cultures 24, 48 and 72 hpi were determined by FFU Assays. Statistical analysis was done by 1way 
ANOVA. Standard error of mean is shown (SEM). 
 
Neuronal cells are highly susceptible to LGTV in vitro and more than 50 % cells are 
infected 72 hpi (A, B). No differences could be determined between WT and IRF-7-/-. 
Similarly the amount of infective virus particles was quantified (C). Even though viral 
levels increase over time again no difference were seen comparing both genotypes. This 
differs from the in vivo situation (Fig.28). More IRF-7-/- neurons were infected which is 
probably due to enhanced viral replication in the CNS of IRF-7-/- animals in vivo.  In vitro 
hippocampal neuronal cells from WT and IRF-7-/- are equally sensitive to infection with 
LGTV with similar kinetics.  
Even though cells can be comparably well infected, the antiviral response in IRF-7-/- 
neurons might differ. Due to the missing feedback loop for type I IFN amplification which is 
mediated by IRF-7, the ability of these cells to secrete IFN might be impaired. Therefore 
the secretion of type I IFNs was analysed in neurons upon infection (Fig. 30).  
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Fig.30: Type I IFN response in infected neuronal cells in the absence of IRF-7. Supernatants 
of WT and IRF-7-/- hippocampal neurons infected with LGTV (MOI 0.001) were tested in a bioassay 
for secretion of type I IFNs, 72 hpi (n≥5). IFN was determined as Units per ml. Statistical analysis 
was done by 1way ANOVA and standard error of mean is shown (SEM). 
 
WT Neurons were able to produce type I IFN upon infection with LGTV. Although IRF-7 is 
responsible for the positive amplification loop in IFN induction no differences were 
detected between WT and IRF-7-/- cells. This indicates that IRF-7-/- neuronal cells can 
induce type equal amounts of type I IFN in an IRF-7 independent manner. Thus, even 
though neuronal cells are highly infected, they do not contribute to differences in infection 
that were seen in the in vivo model.  
Other brain resident cells might intervene decisively in the infection process. Astrocytes 
for instance are known to contribute to the protection of neuronal cells by type I IFN 
induction and growth factor secretion [166]. Since also a higher number of astrocytes 
were infected in vivo, these cells might be affected by the loss of IRF-7. First of all, the 
response of these cells to LGTV infection was tested (Figure 31).  
 
Fig.31: Susceptibility of astrocytes to LGTV infection in the absence of IRFs in vitro. Primary 
WT, IRF-3-/- and IRF-7-/- Astrocytes were infected with LGTV, MOI 0.1. Viral particles in 
supernatants were tested in the FFU Assay for infective virus particles at 24, 48 and 72 hpi (n≥5). 
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The statistical analysis was performed with 1way ANOVA, *** p˂0.0001 and the standard error of 
mean is applied (SEM).   
 
Nearly no infectious virus particles could be determined in LGTV exposed WT astrocytes. 
Whereas IRF-3 deficient astrocytes show only low level of viral replication, astrocytes 
which lack IRF-7 show an high increase of viral replication during the course of infection. 
This indicates that viral replication is effectively restricted by IRF-7 in astrocytes or that 
cells are more susceptible to initial infection.  Thus, a specific role for IRF-7 in the 
protection of glia cells during LGTV infection is implicated.  
IRF-7 plays a role in the amplification of type I IFNs. We therefore determined the type I 
IFN response in these cells (Figure 32).  
                                 
Fig.32: Elevated type I IFN response in infected astrocytes in the absence of IRF-7. WT, IRF-
3-/- and IRF-7-/- astrocytes were infected with LGTV, MOI 0.1 and supernatants of uninfected and 
24, 48 and 72 hpi tested for type I IFN responses in a reporter assay (n≥5). The statistical analysis 
was done by 1way ANOVA, *** p˂0.0001. Standard error of mean is shown (SEM).   
 
WT astrocytes show higher basal IFN levels in the uninfected state compared to IRF-3-/- 
and IRF-7-/- cells. This indicates that astrocytes might be pre-activated and therefore able 
to induce faster immune responses. However, very low number of infective virus particles 
were found in WT astrocytes at all tested time points after infection (Fig.31). This suggests 
low viral replication induces only a very low type I IFN levels in WT astrocytes. The same 
correlation between low viral replication and low induction of type I IFN was found in IRF-3 
deficient astrocytes. Surprisingly, despite the defective positive amplification loop 
depending on IRF-7, high amounts of type I IFN are secreted by IRF-7-/- astrocytes. This 
indicates that type I IFN can be induced in astrocytes in an IRF-7 independent manner 
(Fig.32).  
The high type I IFN production by IRF-7 deficient astrocytes could be due to the high 
abundance of PAMPs and thereby increased triggering of the early type I IFN response, 
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or by the ability of the astrocytes to produce type I IFNs. To further investigate this, 
astrocytes were transfected with polyinosinic-polycytidylic acid (poly I:C) which is used as 
a synthetic analogue of dsRNA. The type I IFN induction was compared between WT and 
IRF-7-/- astrocytes (Fig.33).  
 
Fig.33: Poly I:C stimulated type I IFN production by IRF-7 deficient astrocytes. WT and IRF-7-
/-
 astrocytes were transfected with 0.05, 0.25 and 0.5 µg poly I:C or left untreated (n=3). Type I IFN 
was measured by bioassay at 24 hours post transfection (hpt). Statistical analysis was done by 
1way ANOVA, *** p˂0.0001. Standard error of mean is shown (SEM).   
 
Poly I:C induces a concentration dependent induction of strong type I IFN response in 
astrocytes . The response of WT and IRF-7-/- astrocytes is dependent on the amount of 
poly I:C that was deployed. However, no significant differences between WT and IRF-7-/- 
astrocytes were detected. This indicates that the ability of these astrocytes to produce 
type I IFN is dependent on the amount of PAMPs. Thus the stronger IFN response in IRF-
7-/- astrocytes results from the higher susceptibility to the virus infection, with is associated 
with higher amount of PAMPs. In addition this verifies an IRF-7-independent induction of 
type I IFN response in astrocytes.  
 
Microglia, might also contribute to a protective type I IFN response next to astrocytes as 
shown for other infections [167]. Therefore microglia were tested for type I IFN secretion 
in vitro as well (Figure 34).  
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Fig.34: Type I IFN response elicited by infected microglia in the absence of IRF-7. WT 
and  IRF-7-/- microglia were separated from mixed glia cultures, cultivated and LGTV infected with 
an MOI of 0.1. Secreted type I IFN was determined by reporter assay and is depicted as Units/ml 
(n=6). Statistical analysis was done by 1way ANOVA, *** p˂0.0001. Standard error of mean is 
shown (SEM).   
 
Increasing amounts of type I IFNs are produced by WT microglia during the course of 
LGTV infection. A similar rise was also seen in IRF-7-/- microglia, however significantly 
higher than in WT. This shows that also microglia were able to elicit high IFN responses in 
the absence of IRF-7 similar to astrocytes. Still, microglia cultures are often 
heterogeneous due to the isolation process and might still contain astrocytes which also 
contribute to the type I IFN production.  
 
2.4.3. Type I IFN responses to neurotropic LGTV in the absence of IRFs  
 
The induction of inflammatory factors such as type I IFN is dependent on the interplay of 
several different cell populations in vivo. To evaluate if higher type I IFN responses can be 
verified in systemic infections, IFN-reporter mice (IFN-β+/∆luc) and IFN-β+/∆luc mice deficient 
for IRF-3 and IRF-7 were used for in vivo imaging (Figure 35).   
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Fig.35: Type I IFN induction visualized in a LGTV infected IFN-β+/∆luc reporter mouse model. 
IFN-β+/∆Luc, IFN-β+/∆Luc IRF-3-/- and IFN-β+/∆Luc IRF-7-/- mice (n≥3) were infected i.p. with 1x 104 FFU 
LGTV. Subsequent to in vivo application of luciferin, uninfected and infected mice were monitored 
0, 2, 4 and 7 dpi during infection in the IVIS system. Representative mice of each group are 
displayed here in a dorsal position. The scale indicates the number of photons (p) measured per 
seconds (s) per cm2 per steradian (sr).  
 
In vivo imaging reveals an increase in type I IFN induction in the course of LGTV infection 
until 7 dpi in IFN-β+/∆Luc, IFN-β+/∆Luc IRF-3-/- and IFN-β+/∆Luc IRF-7-/- mice.  A much stronger signal 
was seen in IRF-7-/- animals compared to WT and IRF-3-/- mice. IFN-β expression in WT 
and IRF-3-/- mice is restricted to the CNS and the spinal cord, whereas robust IFN levels 
were detected in the CNS and the periphery of IRF-7-/- mice. This peripheral type I IFN 
induction that was seen in lymphoid organs and lung in earlier experiments (Fig. 8 and 9). 
Whereas in the periphery the producing cell type is not known, increased IFN-β 
expression in the CNS is attributable to IFN producing microglia and astrocytes in the 
absence of IRF-7.  
 
Considering the correlation of type I IFN induction to viral levels, the IFN induction was 
checked for different brain parts. Since the viral load was highest in the olfactory bulb, the 
IFN induction in this region should be the highest (Figure 36).  
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Fig.36: Type I IFN induction is highest in the olfactory bulb of IFN-β+/∆luc IRF-7-/- reporter 
mice. Brains of systemically with LGTV infected IFN-β+/∆Luc, IFN-β+/∆Luc IRF-3-/- and IFN-β+/∆Luc IRF-
7-/- mice (n≥5) were isolated and cell extracts of olfactory bulb (A), cerebrum (B), cerebellum (C) 
and brain stem (D) were checked for luciferase activity and represented as RLU per ml and 
normalized to 1 g of tissue. Statistical analysis was done by 1way ANOVA. Standard error of mean 
is shown (SEM).   
 
Very low type I IFN induction was found in WT animals. Even though WT and IRF-3-/- 
animals are able to mount protective type I IFN responses in LGTV infection in vivo, the 
signal of IRF-7-/- mice is significantly higher in all tested brain parts, 7 dpi. Corresponding 
to viral load, type I IFN levels are strongest in the olfactory bulb (A). This shows once 
more that enhanced viral replication induces stronger type I IFN expression in the brain of 
IRF-7-/- animals.  
 
2.4.4. Viral clearance in the absence of IRFs 
 
Increased viral levels in the absence of IRF-7 elicit enormous type I IFN production which 
is induced at high expenses even without relying on the IRF-7 positive feedback loop (A-
D). This raises the questions about the effectiveness of viral clearance from the CNS. Is 
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type I IFN sufficient or does the loss of IRF-7 affect the course of infection beyond the 
acute phase? This question was addressed by the validation of viral presence in the CNS 
when animals appear again healthy and body weight returned to the level of recovered 
WT animals (see Fig.6). Results are shown in Figure 37.  
 
Fig.37: In the absence of IRF-7, LGTV is able to persist in the brain. WT and IRF-7-/- mice were 
infected i.p. with 1x 104 FFU LGTV and organs isolated 7 and 15 dpi. Brains were fixed and 
embedded and 30 µm sections used for IHC analysis. Brain sections were stained for viral E 
protein and nuclear cells by DAPI. Pictures of the olfactory bulb were taken at a magnification of 
20x and the scale bar is indicated (200 µm).  
 
Few viral signals can be detected in the olfactory bulb of infected WT animals 7 and 15 
dpi. In contrast, a clear virus signature can be shown in the olfactory bulb of IRF-7-/- 
animals 15 dpi. This shows that even though higher type I IFN levels were elicited, this 
was not sufficient to clear the virus from the CNS. Even after the acute phase of infection, 
the virus can persist in the brain of IRF-7-/- animals.  
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3. Discussion 
 
Innate immunity ensures a fast response against invading pathogens and coordinates the 
activation of the adaptive immune response [27]. This defence is mediated on several 
levels by interlocking mechanisms, such as the complement system, the production of 
cytokines and the engagement of cellular components [42][168,169]. Ideally this results in 
a reduced propagation of the pathogen and subsequent clearance [170]. However, 
defects in the innate immune response often lead to a more widespread dissemination of 
the pathogen, the involvement of different organs and subsequently, a functionality loss 
[20][171]. This might ultimately result in death of the host [71].  
 
3.1. LGTV recognition by RLRs and TLRs is crucial for survival 
  
The type I IFNs plays a crucial role in the control of viral infections [20][151]. Viral 
recognition by cytosolic receptors such as RIG-I and MDA5, as well as endosomal  
receptors like TLRs have been shown to protect the host by the activation of the type I IFN 
signalling pathway [151][172]. Type I IFNs induce the expression a broad range of 
defence molecules which regulate cellular mechanism such as cell survival, proliferation 
and secretion of other inflammatory factors [44][52].  
LGTV, a virus of the TBEV serogroup, is able to evade early innate immune recognition 
and interferes with type I IFN production in the host [132][173]. Still, hosts with a functional 
immune are able to clear systemic infections [20].  
Defects in viral recognition and type I IFN production, such as the loss of IFNAR, led to 
viral replication and systemic spread of the virus which cannot be controlled by the host 
[20]. In contrast, the loss of IFN-β, a type I IFN, did not result in diminished survival in 
mice [20]. This indicates that the function of some signalling components can be 
compensated whereas others are crucial for survival.  
Further components of the type I IFN induction pathway are needed for viral defence in 
LGTV infection. TRIF, which forwards signals of viral recognition by TLR3, was not 
needed for mouse survival of LGTV infection. Still, deficiencies in TLR3 signalling might 
play a less obvious role in antiviral defences as it was shown in other viral infections [174]. 
A study on human patients also indicated a role for TLR3 in TBEV infection [126]. These 
differences might be explained by variations in the pathogenicity of TBEV strains 
compared to the attenuated LGTV strain TP21  [20][175].Differences in the innate 
immunity between the human and the rodent system have to be considered as well 
[111][176]. It was shown that TLR3 is not only differentially expressed on murine and 
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human immune cells but the receptors react differently to pathogenic stimuli like LPS or 
the synthetic analogous of double stranded RNA, poly I:C [176–179].  
Myd88 which functions as adaptor molecule for endosomal TLRs such as TLR7 and TLR9 
was indispensable for survival. A similar important role was determined for RIG-I and 
MDA5 adaptor molecule IPS-1. Therefore both, endosomal and cytosolic virus recognition 
is needed in the defence of LGTV. Cytosolic sensors were needed for early recognition, 
whereas TLR7 and TLR9 mediated signalling led to a delayed onset of symptoms. Since it 
is known that TBEV is able to hide initial replication in the endoplasmic reticulum, a similar 
mechanism might be proposed for LGTV [180]. Viral material is probably not only secreted 
into the cytosol, but might also be transported from the ER through the endomembrane 
system of the Golgi apparatus to endosomes. This might provide an explanation for the 
late recognition of virus RNA by endosomal TLRs.  
Differences in the time line for TLR and RLR signalling might also reflect a specific role of 
these receptors in the periphery or the CNS upon infection. It is known that type I IFN 
induction in the periphery controls viral replication. A delayed peripheral IFN response 
might facilitate initial viral replication and early spread to the CNS where the virus can not 
be controlled [20]. Differences in RLR and TLR subsets have also been noted in different 
brain parts and might therefore contribute to pathogenesis. A specific role of RLR adaptor 
molecule IPS-1 has been shown for IFN-β expression in the olfactory bulb whereas other 
regions were unaffected [151]. Here, other recognition receptors like TLRs might 
compensate efficiently for the loss of RIG-I and MDA-5 signalling.   
 
3.2. Diverse roles of interferon regulating factors in LGTV infection 
 
Interferon regulatory factors are important to initiate and fine tune the type I IFN response 
upon infection [181]. Whereas IRF-3 plays merely a role in early type I IFN induction, 
mediated by IFN-β, IRF-5 is known to activate the inflammatory NF-κB pathway [31][182]. 
IRF-7 functions as a positive regulator for a reinforced type I IFN response characterized 
by increased IFN-α levels [71]. It was shown that these proteins induce overlapping but 
also distinct antiviral gene sets [183]. It was proposed that IRF-3 and IRF-7 have no 
redundant roles [69]. In this context, infections with different viruses such as WNV, EMCV 
and HSV-1 were lethal in the absence of IRF-3, IRF-5 or IRF-7 [54][71][184]. However, 
distinct virus infections revealed individual roles of these proteins independent of viral 
concentration and route of infection [31][54][184]. Mice deficient for IRF-3 survive HSV-1 
infection, whereas the loss of IRF-7 led to death [71]. In WNV infection, the absence of 
either factor was associated with a lethal outcome [54][185]. The role of IRFs in LGTV 
infection was not known so far. Here it was shown that in systemic LGTV infection, IRF-3 
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and IRF-7 were not essential for survival, whereas the loss of IRF-5 led to 50 % mortality 
in mice. Interestingly, local LGTV infection showed a very different outcome. In the CNS 
survival was dependent on viral quantities. Intermediate viral infection doses led to high 
mortality rates in all animals. In contrast, very low quantities of LGTV were tolerable for 
WT but still lethal for most IRF-3 and IRF-7 deficient animals. This indicates to a specific 
role of IRF-3 and IRF-7 in the CNS during LGTV infection.   
 
3.3. IRFs are protective in peripheral LGTV infection 
 
Even though the loss of IRF-7 did not affect survival, a temporary weight loss indicated a 
potential function of IRF-7 in LGTV infection. In other virus infection models, the absence 
of IRF-3 and IRF-7 was associated with higher viral loads and an increased spread of the 
virus which was now also verified for LGTV infection[54][185].  
Here, LGTV infection caused an activation of the immune system, marked for instance by 
splenomegaly and lymph node hyperplasia. This is often a result of enhanced immune cell 
proliferation [186]. Increased numbers of macrophages, granulocytes and CD8 T cells 
were found in spleens of infected IRF-7-/- animals, without overall changes in the 
microscopic integrity of the organ. These cells are often associated with inflammatory 
processes and migrate to the site of acute infection [146]. 
 Another sign for immune activation was IFN-β induction by LGTV infection. Systemic type 
I IFN was low in the absence of IRF-7, which was similar to results published for WNV, 
EMCV and HSV-1 [54][71]. The local IFN induction was highly elevated in several 
lymphoid and non-lymphoid organs of IRF-7-/- animals. This was surprising, since IRF-7 
was postulated as the master regulator of type I IFNs, where a loss of the protein was 
associated with decreased type I IFN levels [71].  
Especially myeloid immune cell populations, known as IPCs are able to secrete high 
amounts of protective type I IFNs upon infection [150]. It is known that these cells can be 
infected by LGTV [20]. Still, only low infection rates were observed in IRF-7-/- BMDCs but 
an increased susceptibility of IRF-3-/- cells was seen. This does not coincide with in vivo 
data from spleen where enhanced viral level for IRF-7-/- but not IRF-3-/- were detected. 
Therefore local factors and compensation mechanisms like the production of type I IFN 
might contribute to the protection of myeloid IRF-3-/- cells. In fact, differentiated bone 
marrow derived IRF-3-/- pDCs and macrophages showed nearly normal type I IFN 
induction whereas IFN secretion by IRF-7-/- cell was clearly impaired. This corresponds to 
data that shows that IFN production by pDCs is crucially dependent on IRF-7 [71]. Still, 
residual type I IFN secretion was observed in IRF-7-/- macrophages. In WNV infection, 
IFN-α level in IRF-7-/- macrophages were clearly decreased whereas the production of 
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IFN-β was less affected [53]. It can be speculated that enhanced IRF-3 activation leading 
to increased IFN-β expression might at least to some extent compensate for the loss of 
the positive feedback loop mediated by IRF-7. Still, this does not explain the high type I 
IFN induction that was seen in lymphoid organs in the absence of IRF-7.  
To evaluate this phenomenon a more detailed in vivo analysis of the peripheral infection 
would be necessary. Myeloid IRF-7-/- cells might still be able to produce high IFN amounts 
depending on the infection stimulus. Also cell-cell interactions and environmental cues 
might influence the antiviral response. Compensatory functions of IRF-3 and IRF-5 might 
also contribute to the effect[187]. The absence of distinct IRFs can result in the induction 
of modified IFN-α subtypes profiles [27].  
After all, in vitro BMDCs cultures might reflect poorly the systemic impact of LGTV on IRF-
7-/- animals.  
 
3.4. The role of type I IFN signalling in the CNS 
 
The CNS was initially described as immune privileged site, characterized by relatively 
immune quiescence and only minor interaction with components of the immune system 
[188,189]. This was thought to minimize pathogen entry and reduce damage caused by 
activated immune cells in a system that relies on a functional neuronal network for survival 
[188,190,191]. However, in the last decades this hypothesis was seriously challenged 
[188]. Even though barriers like the BBB and the CSFB isolate the organ and control 
exchange of nutrients and signalling molecules, immune cells have been shown to enter 
the CNS actively to scan for foreign antigens [192–194]. Also brain resident cells were not 
as quiescent as initially assumed. Especially microglia and astrocytes take very actively 
part in local immune responses to protect neuronal integrity [195,196].  
Neurons, microglia and astrocytes are able to produce type I IFNs locally in varying 
amounts upon different viral infections [165][169][197]. This local activation mediates the 
production of cytokines, antiviral factors and facilitates enhanced immune cell migration 
into the brain [17][151]. Still, this response is far from homogeneous. Different areas of the 
CNS are more accessible to immune cells and immune responses from brain resident 
cells differ substantially from each other [163][198]. Additionally, differences have been 
described for subpopulations of the same cell type and the maturation status of these cells 
[152][199].  
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3.5. The mechanism of CNS entry in LGTV infection 
 
That LGTV is a neurotropic virus is well established, whereas the mechanism by which 
the virus enters the CNS is still unknown [20][151]. Due to experimental data, several 
routes of infection are imaginable and often a virus uses more than one entry strategy 
[122–124]. Here, defects in the type I IFN response seem to provide pathogens with an 
easier access to a more vulnerable CNS [20][151]. It was shown that the virus can already 
be detected early in the CNS before the inflammatory response leads to a breakdown of 
the BBB in IFNAR mice [20].  
A possible entry strategy is the infection of immune cells, which might enable LGTV to 
enter the CNS undetected by a ´Trojan Horse mechanism´ [20]. Leukocytes which are 
defective in their antiviral response such as seen here for hematopoietic IRF-3-/- cells are 
more susceptible to LGTV infection and might provide a better target for LGTV. Infected 
infiltrating immune cells which continuously patrol the CNS might expose susceptible 
neurons to LGTV.  
We also observed an early and transient viremia in the absence of IRF-7. For many 
different arboviruses a viremia has been described [121]. This might enable the virus to 
spread to different organs and ultimately pass the BBB to gain access to the CNS.       
However, we could also show recently that in IPS-1-/- animals the virus locates especially 
to the glomerular layer of the olfactory bulb [151]. This might indicate an infection of 
olfactory sensory neurons in the periphery, which continue through the cribriform plate 
directly into the exposed olfactory glomeruli [200]. Further research is needed to verify if 
one or several of these entry routes are used by LGTV in systemic infection and which 
impact is due to specific defects in the type I IFN response.  
 
3.6. IRF-7 protects the CNS from increased viral replication 
 
Viral replication in the CNS can occur at the site of entry, but virus can also spread into 
different areas of the brain [200][201]. Viral recognition receptors like TLRs and RLRs 
which recognize PAMPs of LGTV are unequally distributed in different brain resident cells 
and regions of the CNS [202]. Some areas might therefore induce immune responses less 
efficiently than others and therefore the amount of inflammatory cytokines differs 
enormously [195]. In this context, the cytokine profile of cell populations by environmental 
cues is important. Cells of different origin are able to mount faster and more effective 
responses due to higher initial expression of type I IFN associated factors [152].  
In the absence of IPS-1, lower levels of basal IRF-1 and viperin were observed in the 
olfactory bulb. This might explain increased replication of LGTV in this area [151].  
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Similar to LGTV infected IPS-1-/- animals the virus was detected here mainly in the 
glomerular layer of the olfactory bulb. This indicates a certain preference of LGTV for 
glomerular or sensory olfactory neurons. This might be due to regional differences in 
neuronal populations and their maturation status [152][199][203]. Neuronal precursors 
migrate from the hippocampus along the rostral migratory stream (RMS) into the olfactory 
bulb where mainly sensory neurons are continuously replaced [204]. It is not clear, if these 
cells show the same defence and maturation properties like stationary older neurons or if 
there are differences in their cytokine expression patterns. Less mature neurons were 
shown to be more vulnerable in other viral infections which might result in a preference of 
LGTV for the olfactory bulb [205]. However, regions with immature neurons, such as the 
hippocampus, were merely LGTV free [206]. No clear manifestation of the virus in other 
specific brain regions or structures of the CNS were detected.  
Even though the localisation of the virus was similar in all genotypes, viral amounts were 
substantially dependent on type I IFN signalling. The loss of IRF-7 led to increased viral 
amounts in the olfactory bulb. This can be due to higher viral amounts in the periphery 
and subsequently enhanced infiltration of the virus into the CNS. In the absence of IRF-3, 
virus was nearly undetectable in the brain. This indicates that the loss of IRF-3 is 
negligible in systemic infection targeting the CNS, whereas IRF-7 function can not easily 
be compensated by other factors.  
 
3.7. IRF-7 mediates inflammatory processes in the LGTV infected brain 
 
Enhanced propagation of pathogens in the CNS is often associated with inflammation 
[151]. This process is for instance characterized by high cytokine production, microglia 
activation and immune cell infiltration [151]. Cytotoxic side effects can lead to neuronal 
cell death and are therefore tightly controlled [207]. The deficiency of IPS-1 in LGTV 
infection led to increased levels of IFN-β and IL-6, as well as an increase in chemokine 
levels [151].  
Increased level of pro-inflammatory cytokine TNF-α and chemoattractant CCL2 were 
detected here in the olfactory bulb of all infected animals. The amounts increased during 
the course of acute infection and this effect was most pronounced in LGTV infected IRF-7-
/-
 animals. In these mice the upregulated cytokine milieu was accompanied by a high influx 
of infiltrating immune cells into the CNS characterized as monocytes, macrophages, DCs 
and T cells.  
These invading cells play diverse roles in the infected CNS. DCs act as antigen 
presenting cells and directly influence the number and type of T cells that are recruited 
during infection [208]. T cells can be polarized to a Th1 or Th2 fate which is associated 
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with different cytokine profiles [208]. Similar polarizations have also been described for 
macrophages, which can be termed inflammatory M1 or anti-inflammatory M2 cells [209]. 
Due to effector function and cytokine production these macrophages can support survival 
or mediate cell death [209]. Interestingly, more activated IRF-7-/- macrophages but less 
activated IRF-7-/- DCs have been characterized compared to controls. This might influence 
antigen presentation and therefore viral clearance as well as cell survival in the CNS of 
these animals. A similar activation was found in brain resident microglia. The overall 
number of these cells was reduced in the absence of IRF-7. However, cells showed 
increased activation. This might result in microglia conversion to DC like cells with 
improved antigen presenting properties [210,211]. Microglia can also switch to a more 
macrophage-like phenotype by increased CD45 expression in the inflamed CNS [156].  
Interestingly, IRF-7 was shown to play a role in the M1 to M2 polarisation of microglia in 
the brain [212]. In the proposed model, transforming growth factor-beta (TGF-β) was able 
to reduce IRF-7 activity, which was associated with increased TNF-α levels and the 
retention of microglia in the M1 state [212]. Similarly, elevated levels of TNF- α were 
detected here in the absence of IRF-7 and macrophages as well as microglia show an 
activated phenotype. Therefore not only increased viral replication but also an IRF-7 
dependent, CNS intrinsic mechanism might be responsible for increased inflammation in 
the brain of IRF-7-/- animals.   
An increase in the inflammatory response by the lack of IRF-7 might affect cell viability in 
the CNS. LGTV infection was shown to enhance Caspase 3 mediated apoptosis in Neuro-
2a cells in vitro which was at least partly mediated by the E Protein of the virus [131]. In 
vivo the loss of IPS-1 led also to increased apoptosis in the olfactory bulb [151]. No 
enhanced apoptosis was seen in the absence of IRF-7 upon LGTV infection despite 
elevated TNF-α levels and an increase of cytotoxic T cells. Therefore neuronal integrity 
might be largely maintained. However, cell death by caspase independent apoptosis, 
necrosis or autophagy was not explored and might play a role in LGTV infection [213]. 
 
3.8. IRF-7 affects regional and cell specific immunity in neurotropic infection   
 
Often specific cell types of the CNS are targeted by pathogens. Not only neurons but also 
astrocytes can be highly susceptible to virus infections [214,215].  
Neurons have been shown to be the major target of LGTV and TBEV infections in the 
CNS in humans and rodents [20][119]. This was confirmed here, since more than half of 
the differentiated hippocampal neurons were infected by low quantities of LGTV in vitro. In 
vivo, neurons in the olfactory bulb were also highly infected, especially in the absence of 
IRF-7. However, IRF-7-/- neurons were equally vulnerable to LGTV in vitro even though 
57 
 
higher infection rates were observed in vivo. This might be due to higher local viral 
replication in the CNS. 
Additionally, properties of regional neuronal subpopulations might play a role. Neurons 
isolated from cerebellum and cortex did not show the same susceptibility to WNV 
infection, due to differing basal levels of components of the type I IFN signalling pathway 
[152]. Here, only hippocampal neurons were tested. In vivo the virus targets mainly 
glomerular and sensory neurons but not granule cells and mitral cells of the olfactory bulb. 
It can be hypothesized that IRF-7 plays a specific role in the protection of distinct neuronal 
subpopulations. Also other regional cell types like astrocytes and microglia might influence 
the neuronal susceptibility.  
A clear switch in tissue tropism of LGTV was observed in astrocytes in the absence of 
IRF-7. Whereas these cells are normally sparsely infected, IRF-7-/- astrocytes were highly 
affected in vivo and in vitro by LGTV [151]. This shows that IRF-7 protects astrocytes from 
infection as well as viral replication. A higher propagation of LGTV in IRF-7-/- astrocytes 
also exposes more vulnerable neurons to the virus.  
This change in tissue tropism indicates a protective function of IRF-7 especially in 
astrocytes.  
 
3.9. The type I IFN response against LGTV in the brain is independent of IRF-7 
 
 
For the maintenance of CNS functionality, microglia and astrocytes but also neurons 
themselves take active part in pathogen defence, independent from infiltrating immune 
cells [169][195][216]. This can be realized by secretion of growth factor or anti-
inflammatory cytokines [202]. Cells produce for instance local type I IFN which is highly 
protective in viral infections [217]. IFN is secreted and acts in a paracrine and autocrine 
manner [218]. Thereby survival of the producer cells but also of the surrounding 
population is ensured [157].  
Neurons were able to secrete type I IFN upon LGTV infection and this was independent of 
the presence of IRF-7. It was shown by others that only few neurons actually participate 
and proposed a restriction for IFN production in these cells [169]. 
Astrocytes were described as main IFN-β producers in viral infection of the olfactory bulb 
with vesicular stomatitis virus (VSV) [165]. Here, we show that infected IRF-7-/- astrocytes 
secreted very high amounts of type I IFN in LGTV infection in vitro. Interestingly, the ability 
of astrocytes to produce IFN was not impaired in the absence of IRF-7. This shows that 
infected astrocytes do not have to rely on the positive feedback loop mediated by IRF-7, 
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to induce a protective type I IFN responses. The upregulation of the response is merely 
regulated by the strength of the activation stimulus.  
Similarly, microglia showed the ability to induce higher type I IFN responses in the 
absence of IRF-7.  
The mechanism of this high, but IRF-7 independent IFN production is unclear. It was 
shown here, that in the CNS LGTV mediated IFN induction is at least partially due to an 
increase in IFN-β expression. IFN-α induction or compensatory mechanisms were not 
investigated further.  
The IFN-β induction in the olfactory bulb was recently described as dependent on RIG-I 
signalling adaptor molecule IPS-1 [151]. However, the signal amplitude of IFN-β induction 
I in the absence of IRF-7 corresponded clearly to LGTV replication. Even though the 
olfactory bulb might be more vulnerable to LGTV infection, type I IFN induction in the 
absence of IRF-7 is not regionally restricted. 
This raises questions about the positive feedback mechanism of IRF-7. The production of 
protective IFN by brain resident cells in the absence of important type I IFN regulators 
such as IRF-7 might sustain safeguarding mechanisms of the CNS. Many viruses are 
known to interfere with type I IFN components to evade immune recognition 
[173][219,220]. Specific targeting of IRF-7 by neurotropic viruses might be responsible for 
evolutionary pressure on the immune system to develop strategies that are IRF-7 
independent [219][221]. Still, mechanisms to fine tune the antiviral response are probably 
impaired in the absence of IRF-7 [29]. Additionally, the absence of IRF-7 is associated 
with higher viral replication and decreased survival chances in many infections [54][71]. 
Therefore, this regulatory factor is not indispensable for the immune response of these 
animals.  
 
3.10. Effect of type I IFN alterations on inflammatory processes in the CNS 
 
Type I IFNs are employed as anti-inflammatory therapeutics in CNS diseases such as 
virus induced encephalitis or autoimmune diseases like multiple sclerosis (MS) [222,223]. 
Here it was shown that high amounts of IFN-β are induced in the absence of IRF-7. It is 
not clear, if this response is protective or if it has even detrimental effects on animal 
health. Whereas IFN exhibits anti-inflammatory effects in MS, we see enhanced 
inflammation in the absence of IRF-7 [223]. A possible explanation might be provided by 
the altered cell activation in the absence of IRF-7. As already mentioned above, reduced 
levels of IRF-7 can be associated with a switch to a M1 phenotype in macrophages and 
microglia [224]. A pro-inflammatory set of cytokines and chemokines is produced by these 
cells [225,226]. In contrast, anti-inflammatory effects of IFN in MS were due to alterations 
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in the T cell response [227,228]. Even though we could see increased infiltration of T 
cells, it is not clear if these cells contribute to viral clearance in LGTV and TBEV infection. 
The role of specific immune cell populations might therefore also influence the 
effectiveness of IFN treatment.  
Even though we see increased inflammation in the absence of IRF-7 despite type I IFN 
production, we can not exclude a protective role for IFN induction in the CNS. It is quite 
possible that type I IFN still dampens the immune response in these animals. If type I IFN 
would be absent, there might be an even more severe inflammation. Excessive immune 
responses and a lack of type I IFN might be the cause of death in IFNAR-/- and IPS-1-/- 
animals [20][151].  
It can here only be concluded that the production of type I IFN will modulate the immune 
response of IRF-7-/- animals and contributes to viral defence.  
 
3.11. Implications for Flavivirus infection in humans 
 
Even though IRF-7 is dispensable for survival of systemic LGTV infection the virus is able 
to persist in the brain. High induction of type I IFNs, an increased inflammatory response 
and immune cell activation in the absence of IRF-7 did not result in viral clearance in the 
acute phase of infection.  
This has direct indications for patients infected with neurotropic viruses. Defects in the 
type I IFN response might not lead to death, but merely to more pronounced encephalitis 
or meningitis in humans. Inflammation related cytotoxic effects might results in 
neurological long-term effects that are often seen in patients that suffered from 
neurotropic infection [229–231]. Viral persistence might also be responsible for 
neurological sequelae, which was regularly observed in TBEV patients [88][229]. In this 
context, it is not clear if treatment with type I IFN is a sufficient therapeutic option for 
TBEV or other virus associated infections in the CNS [232]. This work clearly shows that 
more detailed knowledge of the immune response in the CNS is needed to efficiently fight 
neurotropic infections in humans.     
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4. Material and Methods 
 
4.1. Materials 
 
4.1.1. Consumables  
 
All consumables used for this work are listed below (Table 1). 
 
Tab.1: List of Consumables 
Material Detail Manufacturer 
Biosphere® Filter Tips 20 µl, 200 µl, 1000 µl Sarstedt AG 
Cell Star Cell Culture Dish PS, 145 x20 mm, vent. Greiner bio-one 
Cell strainer  40 µm, 70 µm BD Falcon 
Ceramic spheres  MP Biomedicals 
Cover glasses Ø 13 mm VWR 
 24 x 50 mm Carl Roth 
Disposable Base molds 37x 24x 10 mm Ted Pella Inc. 
Embedding molds 13x 8x 5mm Plano GmbH 
Inject® single use syringe 2 ml, 5 ml, 10 ml, 20 ml B Braun Medical Corp. 
Micro FineTM Insulin 
syringe 
U-100, 0.5 ml, 0.33 mm x12.7 mm Becton Dickinson GmbH 
Microscope slides Cut edges, frosted VWR 
 Menzel Gläser Superfrost®, cut edges Thermo Fisher Scientific 
Inc. 
Nunc® Micro WellTM plate 96 well, Polystyrene, round bottom Thermo Fisher Scientific 
Inc. 
Pasteur pipettes 150 mm, glass Brand AG 
Safe Seal Micro Tubes 1.5 ml, 2 ml Sarstedt AG 
Serological pipette 2 ml, 5 ml, 10 ml Sarstedt AG 
Single-use syringe Omnican® F, 1 ml, 0.3 mm x 12 mm B Braun Medical Corp. 
Sterican® cannula 0.6 mm x 25 mm 
0.45 mm x 12 mm 
B Braun Medical Corp. 
TC Dish 100 Std. Sarstedt AG 
TC Flask T75, T25, Std, vent. Cap Sarstedt AG 
TC Plate Std. F, 6 well, 12 well, 24 well, 48 well, 
96 well 
Sarstedt AG 
Tip Stack Pack 20 µl, 200 µl, 1000 µl Sarstedt AG 
Tube Concical bottom, 50 ml, 15 ml Sarstedt AG 
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Tube U-bottom bulk, 1.4 ml Micronic 
Tube 2 ml, colourless, sterile, screwtop Biozym Scientific GmbH 
Tube 5 ml, 75 x12 mm, PS Sarstedt AG 
 
 
4.1.2. Chemicals and reagents 
 
Chemicals and reagents are depicted in Table 2. 
 
Tab.2: Chemicals and reagents 
Chemicals/Reagents Manufacturer 
Albumin Fraction V Boehringer Mannheim GmbH 
Avicel FMC Corporation 
Beetle Lysis Juice PJK GmbH 
Chloroform Fluka Analytical 
D-luciferin (in vivo) SynChem OHG 
D-Luciferin (in vitro) PJK GmbH 
Ethanol J.T. Baker 
Goat serum Sigma Aldrich 
Isoflurane Baxter 
Isopropanol J.T. Baker 
Methanol J.T. Baker 
Neo-Mount® Merck KGoA 
PercollTM GE Healthcare 
peqFECT  VWR PeqLab 
peqGOLD TriFast VWR PeqLab 
Poly L-Lysin Sigma Aldrich 
Roti®-Histofix 4 % Carl Roth GmbH 
Succhrose Merck KGoA 
Tissue Tek O.C.T. compund Sakura 
Triton X-100 Serva Electrophoresis GmbH 
Tween-20 Sigma Aldrich  
Tween-80 Sigma Aldrich  
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4.1.3. Buffer and media 
 
All media and supplements were obtained from Gibco® Life Technologies, InSCREENeX, 
Invitrogen, Merck KGoA, Sigma Aldrich and Biochrom AG. Specific buffers are described 
in the according section.  
 
1x PBS 
140 mM NaCl, 27 mM KCl, 7.2 mM Na2HPO4,14.7 mM KH2PO4,  
pH 6.8-7 
 
 
4.1.5. Virus  
 
Langat virus strain TP21 (G. Dobler) was used for all experiments. The virus was 
propagated in Vero B4 cells and virus concentration determined by FFU Assay.  
 
4.1.6. Laboratory Equipment  
 
All devices used for this thesis and the according manufacturers are listed below (Table 
3).  
 
Tab.3: Laboratory equipment  
Device Type Manufacturer 
Autoclave Dampf Sterilisator 6-6-6-HS1, FD Belimed 
Current Power Supply Power Pac 1000 Bio-Rad Laboratories 
Centrifuges Biofuge Pico Heraeus 
 Biofuge Fresco Heraeus 
 CS-15R Beckmann Coulter 
 Cytospin 3 Shandon 
Flow cytometer LSR II Becton Dickinson 
Homogenisator Fastprep 24 MP Biomedicals 
Incubator C200 Labotect 
In vivo Imaging system Xenogen IVIS System Caliper 
Luminometer 9507 Berthold Lumat LB 
Magnetic stirrers hot plate RET basic IKA Werke GmbH 
Micropipettes 10 µl, 20 µl, 100 µl, 200 µl, 1000 µl Gilson 
Microscopes Confocal, LSM 510 Meta Carl Zeiss 
 Labovert Leica 
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 Olympus CK2 Leica 
MilliQ Unit Biocel Millipore Merck KGoA 
Microwave Pro 825 Whirlpool 
Nitrogen Tank 17 K, HarscoK-Series Tayloe Wharton 
pH Meter M340 Beckmann 
Photometer NanoDrop-1000 PeqLab 
Pipette controller Accu Jet pro Brand GmbH 
Scale Precision weighting scale  Sartorius 
Shaker Duomax 1030 Heidolph 
Sterile work bench Herasafe Heraeus 
Thermomixer Thermomixer compact Eppendorf AG 
Water bath 3044 ROWA 
 
4.1.7. Computer software 
 
Data collection, calculation and processing were done with Microsoft (MS) Office 
Professional 2010 Word, Excel and Power Point. To obtain microscopic pictures 
Automated interactive microscope (AIM) program and ZEN imaging software were used. 
Images were processed with ImageJ (National Institute of Health). In vivo images were 
processed with Living Image 3.2 software. Flow cytometry data were acquired with the 
LSR II program FACSDivaTM and FlowJo v10. Graphs and Statistical analysis were 
generated by GraphPad Prism.  
 
4.2. Methods 
 
4.2.1. Animal experiments 
 
Ethics statement 
 
The animal experiments were performed according to the guidelines of the German 
Animal welfare Law (TierSchG BGBl. S. 1105; 25.05.1998). The approved animal code for 
the experiments is 11/0528.  
 
Animal housing 
 
Animals were bred and cared for at the animal facility of the Helmholtz Centre for Infection 
research in Braunschweig or the animal house at the Otto-von-Guericke University, 
Magdeburg. C57BL/6 WT animals were obtained from ENVIGO. Transgenic mice on a 
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C57BL/6 background were kept under SPF conditions and the genotype was verified by 
PCR. 
Mice were maintained in individually ventilated IVC Green Line cages (Tecniplast 
Germany GmbH) separated according to their gender. Mice had access to food and water 
ad libitum and were kept under standardized conditions, such as a 12 to 12 or 14 to 10 
hour light-dark cycle, 50 lux illuminance, at 55 % humidity and 22 °C.  
 
Anesthesia 
 
Mice were anesthetized with 100 µl/ 10 g body weight of a 10 % ketamine (WDT), 5 % 
Xylazin (CD-Pharma) mixture in 0.9 % NaCl for i.c. injections.  
For in vivo imaging animals were anesthetized continuously with Isoflurane (Baxter) in a 
rodent anesthesia chamber or the IVIS 200 integrated anesthesia unit.  
 
Virus infection 
 
6-12 week old mice were used for experiments. Animals were intraperitoneally injected 
with 100 µl 1x 104 FFU LGTV TP21.  For intracranial infection mice were anesthetised as 
described above. Unconscious mice were injected intra cranially with 20 µl 1x 101 or 1x 
102 FFU LGTV into the posterior fontanel. Virus was always diluted in 1x PBS.  
 
In vivo Imaging 
 
IFN-β+/∆luc, IFN-β+/∆lucIRF-3-/- and IFN-β+/∆lucIRF-7-/- mice were systemically infected with 
LGTV. Prior to in vivo imaging, mice were inoculated intravenously with 100 µl D-luciferin 
(150 mg/kg in PBS, SynChem OHG). Mice were anesthetized and monitored in the IVIS 
200 imaging system (CaliperLS) for 2 minutes.  The relative intensity of emitted light was 
detected and can be displayed as a pseudocolor image ranging from red (high) to blue 
(low). Signals were measured as photon flux and quantified as radiance p/sec/cm3/sr. For 
image acquiring and processing the Living Image 3.2 software was used. 
 
Blood isolation 
 
Mice were sacrificed by CO2 asphyxiation. The body cavity was opened and blood drawn 
with a single use syringe directly from the heart. To obtain serum, blood was allowed to 
coagulate for 2h at RT and was centrifuged down for 30 min at 2000 xg. The clear layer 
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was collected as serum and stored at -20 °C. For inactivation, serum was incubated for 20 
min at 56 °C.  
 
4.2.2. Cell culture 
 
Dulbecco´s Modified Eagle Medium (DMEM), supplemented 
DMEM (Gibco® Life Technologies) was supplemented with 100 U/ml penicillin, 100 µg/ml 
streptomycin, 2 mM Glutamine, 1 mM Natrium Pyruvate and 10 % fetal calf serum (FCS).  
 
RPMI 1640, supplemented 
RPMI 1640 (Gibco® Life Technologies) was supplemented with 10% FCS, 10 mM 
HEPES, 1 mM sodium pyruvate, 2 mM Glutamine, 100 U/ml penicillin, 100 µg/ml 
streptomycin and 0.1 mM 2-ME. 
 
Gey´s balanced salt solution (GBSS), supplemented 
0.22 g CaCl2 x H2O, 0.37 g KCL, 0.03 g KH2PO4, 0.21 g MgCl2 x6 H2O, 0.07 g MgSO4 x7 
H2O, 8 g NaCl, 0.227 g NaHCO3, 0.120 g Na2HPO4, 1 g D-Glucose were filled up to 1l 
H2O, filtered and keep at 4°C. 
 
Neurobasal Medium, supplemented 
2 % B27 (Gibco® Life Technologies), 1x N-2 (Gibco® Life Technologies) and 0.5 mM 
Glutamine were added to Neurobasal medium (Gibco® Life Technologies).  
 
Trypsin-EDTA 
8 mM EDTA, 0.1 % trypsin, 1x PBS 
 
Cells were handled only under a sterile workbench with vertical air flow. All media and 
buffer were autoclaved or filtered and pre-warmed to 37 °C before use. Working materials 
were disinfected with 70 % Ethanol prior to work. Cells were grown at 37 °C with 5 % CO2 
and 95 % relative humidity. Cells were passaged when they reached 90 % confluency. 
Cells were washed in 1x PBS and incubated with Trypsin-EDTA for 1 min at 37 °C. The 
enzymatic reaction was stopped with supplemented DMEM and cells were transferred into 
a fresh flask with new medium.  
 
Immortalized kidney derived epithelial Vero B4 cells from green monkey were maintained 
in supplemented DMEM. Epithelial cells IEC-Mx2Luc-10 isolated from Mx2-Luc reporter 
mice were grown in IEC Medium (InSCREENeX GmbH) [233][234].  
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Primary hippocampal neurons 
 
E18.5 old WT and IRF-7-/- mouse embryos were sacrificed by decapitation and brains kept 
in 4 °C supplemented GBSS. Hippocampi were isolated and enzymatically disintegrated in 
trypsin supplemented medium at 37 °C for 30 min. Cells were then separated by 
mechanical forces using sterile pasteur pipettes. Cells were counted and 70.000 primary 
hippocampal neurons seeded on Poly-L-Lysine coated sterile cover slips in supplemented 
Neurobasal medium. Cells were differentiated for three weeks with a partial medium 
exchange every 7 days and inocculated with LGTV at an MOI of 0.001 for 1.5 h. Cells 
were supplemented with their own media and incubated for 24, 48 and 72 hpi. 
Supernatants were harvested and tested for IFN secretion and quantified for viral 
particles.  
 
Primary astrocytes and microglia 
 
Postnatal mice at the age of P1-P3 were killed by decapitation and whole brains 
homogenized into 4 °C cold HBSS (Gibco®). Cell aggregates were disintegrated in 
DMEM supplemented with 10% FCS, 1% N-2, 0.5 mM Glutamine, 0.1 U/mL penicillin and 
0.1ug/mL streptomycin. 2,5x 104 cells/ cm2 were seeded on Poly D-Lysine coated (50 
µg/ml) culture flasks and medium was changed 24 hours after isolation. Medium was 
renewed every 7-8 days and cells passaged at least three times before infection 
experiments. From these mixed glia cultures, microglia were removed by shaking at 600 
rpm, 1 h, RT. 70.000 astrocytes or microglia were seeded on poly-D Lysine coated cover 
slips. Cells were infected with LGTV at an MOI 0.1 for 1 h or transfected by peqFECT with 
different concentrations of polyI:C. To determine secreted type I IFN and to quantify the 
virus, supernatants were harvested for infections at 24, 48 and 72 hpi and for polyI:C 
treatment, 24 hpt.  
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Bone marrow derived DCs and macrophages 
 
Bone marrow were isolated by flushing femur and tibia of mice with 1x PBS. Cells were 
washed with 1x PBS and counted. Cells were seeded at a density of at least 1.5 x 106 
cells/ ml in supplemented RMPI 1640 medium.  The X63-GM-CSF cell line was employed 
for GM-CSF production (kindly provided by Dr. Brigitta Stockinger, Division of Molecular 
Immunology, National Institute of Medical Research, London, U.K.) and FL B16 cells for 
Flt-3 secretion [235].  
BMDCs were cultivated for 8 days supplemented with 100ng/ml GM-CSF to generate 
adherent macrophages and mDCs suspension cultures. Similarly, 100 ng/ml Flt-3 was 
used to differentiate pDCs from BMDCs. The medium was renewed once, 4 days after 
seeding, by replacement of two-thirds of the medium. Differentiated macrophages, mDCs 
and pDCs were infected with LGTV at an MOI of 0.5 for 1h at 37°C. Supernatants were 
collected at 24, 48, 72 hpi and viral replication and type I IFN production were quantified. 
Cells were fixated and by cytospin centrifugation (800 rpm, 8 min, RT) transferred to 
microscope slides. Cells were stained by immunohistochemistry and at least 70 cells per 
sample (n=5) quantified for infected cells per DAPI positive cells.  
 
4.2.3. Focus Forming Unit Assay 
 
Infection medium 
1x DMEM, supplemented with 2 % FCS, 2 mM Glutamine, 100 U/ml penicillin and 100 
µg/ml streptomycin.  
 
Avicel-DMEM media 
1.5% Avicel RC/CL and 2x DMEM were used in a 1:1 ratio and supplemented with 10 % 
FCS, 2 mM Glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin. 
 
Permeabilization buffer 
0.5 % Triton X-100 and 20mM glycine in 1x PBS.  
 
Wash solution 
All incubation steps were followed by three wash steps with 0.05 % Tween 80 in 1x PBS. 
 
LGTV was quantified from supernatants by focus-forming assay as described previously 
[151]. Vero B4 monolayers were incubated with serial dilutions of LGTV samples in 
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infection medium for 1h at 37 °C. After removing the inoculum, cells were overlaid with 
Avicel-DMEM medium and after 24, 48 and 72h, cells were fixed with 6 % 
paraformaldehyde. All further steps were performed at RT. Cells were permeabilized for 
20 min in permeabilization buffer and LGTV specific mouse anti-TBEV E-Protein MoAb 
19/1786 [236] was used to detect viral foci. A secondary rabbit anti-mouse horseradish 
peroxidase (HRP)-conjugated antibody (Jackson, # 315-035) was used for detection and 
LGTV positive foci were visualized by TrueBlue staining (KPL, Gaithersburg). 
 
4.2.4. Flow Cytometry 
 
FACS Buffer 
2 % FCS in 1x PBS was used for washing and antibody dilution.  
 
Systemically infected as well as uninfected mice were killed by CO2 inhalation.  Mice were 
perfused trans-cardially by 20 ml 1x PBS. Brains and spleens were harvested and organs 
homogenized through a 70 µm cell strainer into DMEM medium. A discontinuous 30 to 70 
% percoll gradient was used to separate cells in brain samples. Total cells per brain or 
spleen were counted by a Neubauer chamber. All samples were saturated with FcR 
Blocking reagent (MiltenyiBiotec) and stained with antigen specific fluorescent antibodies 
(Table 4). Cells were fixed with 2 % Histofix diluted in 1x PBS and the analysis was done 
by BD LSRII using BD FACS Diva and FloJo software (FloJo V10). Single cell staining of 
spleen were used for manual compensation in all experiments.  
 
Tab.4: Antibodies for flow cytometry analysis. 
Antigen Species Reactivity Fluorophor Company 
B220 Rat Mouse PE-Cy5 eBioscience 
CD4 Rat Mouse APC BD Pharmingen 
CD8a Rat Mouse Pacific Blue BioLegend 
CD11b Rat Mouse PE-Cy7 eBioscience 
CD11c  Armenian 
Hamster 
Mouse FITC eBioscience 
CD45 Rat Mouse PerCP-Cy5.5 eBioscience 
CD80 Armenian 
Hamster 
Mouse PE eBioscience 
Ly-6C Rat Mouse APC-Cy7 BioLegend 
Ly-6G Rat Mouse PE eFlour 610 eBioscience 
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Isolated cells from spleen were separated according to their surface marker expression as 
displayed in Figure 38.  
 
Fig.38: FACS Gating of splenocytes. Cells were isolated from infected and uninfected animals 
and splenocytes were measured by Flow Cytometry. Gating of infected WT cells is representatively 
described here. Dead cells and doublets were excluded by forward scatter (FSC-A and FSC-H) 
and sideward scatter (SSC-A) as illustrated (A, B). Single cells were separated by CD11b 
expression into CD11b+ myeloid, CD11b- lymphoid and Nkp46+ NK cells (C). Lymphoid cells (C) 
were characterized further by CD8a and CD4 expression into CD4+ T cells and cytotoxic T cells 
(CTL) as shown (D). CD8a and CD4 negative lymphoid cells were identified by B220 expression as 
B cells (E). Myeloid cells (C) were segregated by Ly-6C and Ly-6G expression into macrophages, 
granulocytes (GC) and monocytes as depicted (F).  
 
Isolated cells from brain were characterized as shown below (Fig. 39).  
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Fig.39: FACS Gating of brain isolates. Cells were isolated from brains by percoll gradient of 
infected and uninfected animals as described above. Flow Cytometry analysis of infected WT and 
IRF-7-/- are shown as representatives. Cell aggregates and doublets were excluded from the 
analysis by forward and sideward scatter (A, B). Infiltrating immune cells were segregated from 
brain resident microglia by CD45 expression (C). Infiltrating cells were further characterized by 
CD11b and CD11c expression into CD11b+ myeloid cells, CD11b- lymphoid cells and CD11c+ DCs 
as depicted (D). The lymphoid population contained CD4+ and CD8+ T cells (E). The myeloid 
population was separated again by Ly-6C and Ly-6G expression into macrophages, granulocytes 
and monocytes as illustrated (F). 
 
4.2.5. Immunohistochemistry and Histology 
 
Citrate buffer 
10 mM Na3C6H5O7 x2H2O and 0.05 % Tween 20 were dissolved in MilliQ and adjusted to 
pH 6.0. 
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Cells from cell culture experiments were fixed with Histofix for 30 min at RT under the 
hood. Prior to staining with chicken anti-NS3 antibody, cells needed to undergo heat-
induced antigen retrieval. Therefore these cells were submerged in citrate buffer and 
heated to 100 °C for 2 min.  
For histology, mice were killed by CO2 asphyxiation and perfused with 20 ml 1x PBS.  40 
ml 4 % Histofix.  
Fixed cells or tissues were then washed for two times in 1x PBS and incubated for 1h at 
RT in blocking solution containing 10 % goat serum, 0.2 % Triton X-100, 1 % Albumin in 
1x PBS. The first antibody was added for 1h at RT or 4 °C o.n. in 0.2 % Triton, 10 % goat 
serum in 1x PBS. Cells were washed three times for 5 min in 1x PBS and then the second 
antibody was added for 1h at RT or 4 °C o.n.. Antibodies used for staining are shown in 
Table 5 and 6 below. Pictures were taken at the confocal microscope LSM 510 Meta at a 
magnification of 40x.  
 
Tab. 5: Primary antibodies used for IHC and histology 
Antigen Species Reactivity Fluorophor Clone Company 
B220 Rat Mouse PE RA3-6B2 BD Pharmingen 
CD8a Rat Mouse PE 53-6.7 BD Pharmingen 
CD11b Rat Mouse PE M1/70 eBioscience 
E Protein Mouse Virus none MoAb 19/1786 [236] 
F4/80 Rat Mouse PE BM8 eBioscience 
GFAP Rabbit Mouse none polyclonal SYnaptic SYstems 
GFAP Guinea pig Mouse none polyclonal SYnaptic SYstems 
IBA-1 Rabbit Mouse none polyclonal SYnaptic SYstems 
NeuN Guinea pig Mouse none polyclonal SYnaptic SYstems 
NS3 chicken Virus  none   
 
Tab.6: Secondary antibodies used for IHC and histology 
Species Reactivity Fluorophor Company 
Goat Mouse IgG F(ab´)2 Alexa Flour647 Jackson Laboratories Inc. 
Goat Guinea pig IgG (H+L) Alexa Flour 488 Jackson Laboratories Inc. 
Goat Rabbit Cy3 Dianova 
Rabbit Chicken IgY (H+L) FITC ThermoScientific 
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4.2.6. Interferon Reporter Assay 
 
IFN-sensitive epithelial cells from Mx2-Luc reporter mice were grown in IEC medium 
[234]. Cells were overlaid with supernatants or heat inactivated serum samples as 
described previously [233]. Serial dilutions of IFN-β were used to determine a standard 
curve. The inoculum was removed after 24h at 37 °C and cells were lysed in Reporter 
Lysis buffer (Promega). Luciferase activity was determined by D-Luciferin conversion and 
Relative light units (RLU) measured by Berthold Luminometer Luma 9507. 
 
4.2.7. IFN quantification from organs of IFN-β+/∆luc mice 
 
IFN-β+/∆luc, IFN-β+/∆lucIRF-3-/- and IFN-β+/∆lucIRF-7-/- mice were infected with 1x 104 FFU 
LGTV. Uninfected as well as infected animals were sacrificed after 0,2,4, and 7 dpi by 
CO2 inhalation and perfused with 20 ml 1x PBS into the heart. Different organs and 
lymphoid tissues were isolated, frozen in liquid nitrogen and stored at -20 °C. For 
quantification of luciferase activity, organ samples were weighed and overlaid with 
Reporter Lysis Buffer (Promega). The tissue was homogenized by Fast Prep-24 and 
centrifuged at 2000 rpm for 45 min at 4 °C. Supernatants were collected and frozen at -20 
°C. Thawed supernatants were added to D-Luciferin and luciferase activity measured by 
Berthold Luminometer. Results are depicted as RLU calculated to 1 ml and normalized to 
1 g tissue weight. Due to the low weight of lymph nodes, these values were not 
normalized to tissue weight. 
 
4.2.8. Gene expression analysis 
 
TriFast was added to mouse organs and tissue homogenized by Fast Prep-24.  RNA 
isolation was done as described [237]. RNA was extracted from serum by QIAamp Viral 
RNA Mini Kit (Cat.No. 52904, QIAGEN. RNA concentrations were quantified by NanoDrop 
and 1µg RNA was used for cDNA synthesis with RNA First-strand cDNA synthesis kit 
(GE, Healthcare). QPCR was performed with KAPA SYBR FAST Universal Master Mix 
(PeqLab, # 07-KK4600-02). The murine primers CCL2 (forward primer 3´-
GCCCCACTCACCTGCTGCTA-5´, reverse primer 3´-TTTACGGGTCATCACATTCAA-5´) 
and TNF-α (forward pimer 3´- GAACTGGCAGAAGAGGCACT -5´, reverse primer 3´- 
AGGGTCTGGGCCATAGAACT-5´) were used for qPCR. A KAPA probe FAST qPCR kit 
based on a LGTV NS3 Taq-Man assay (forward primer 5´AACGGAGCCATAGCCAGTGA 
3´, reverse primer 5´AACCCGTCCCGCCACTC 3´, probe FAM-
AGAGACAGATCCCTGATGGMGB) was used to quantify viral concentrations. Samples 
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were measured by Light Cycler 480 II (Roche). The program included 40 cycles of 
denaturation (95 °C, 10 s), annealing (60 °C, 30 s) and elongation (72 °C, 10 s). CP 
values for LGTV were normalized to housekeeping gene β-Actin, calculated by the ∆CT 
method and arbitrary units determined based on uninfected WT samples. 
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Abbreviations 
 
au  arbitrary units 
BBB  blood brain barrier 
BSA  bovine serum albumin 
BSL  biosafety level 
BMDCs bone marrow derived cells 
BMDM  bone marrow derived macrophages 
°C  degree Celsius 
CCL  Chemokine (C-C motif) ligand 
CCr  C-C chemokine receptor type 
CD  cluster of differentiation 
CLRs   C-type lectin receptors 
cm  centimeter 
CNS  central nervous system 
CP  crossing point 
CSFB  cerebrospinal fluid barrier 
CXCL  chemokine (C-X-C motif) ligand 
DAPI  4',6-diamidino-2-phenylindole 
DBD  DNA-binding domain 
DCs  dendritic cells 
DENV  dengue virus 
dpi  days post infection 
cAMP  Cyclic adenosine monophosphate 
CREB  cAMP responsive element binding protein  
EMCV  Encephalomyocarditis virus 
ER  endoplasmatic reticulum 
FCS  fetal calf serum 
FFU  Focus forming units 
g  gram 
GAS  gamma-IFN activated sites 
GC  granulocytes 
Hpi  hours post infection 
Hpt  hours post transfection 
HSV  Herpes simplex virus 
IAD  IRF associated domains 
i.c.  intra cranial 
IFN-β/α Interferon alpha/beta 
IFNAR  IFN-α/β receptor 
IFNGR  IFN-γ gamma receptor 
IHC  immunhistochemistry 
IKKε  IkB kinase ε 
IL  Interleukin 
i.p.  intra peritoneal 
IPCs  IFN producing cells 
IPS-1  IFN-β promotor stimulator -1 
IRF  interferon regulatory factor 
ISGF3  IFN-stimulated gene factor 3 
ISGs  IFN stimulated genes 
ISRE  IFN stimulated response element 
Jak  Janus kinase 
JeV  Japanese encephalitis virus 
kDa  kilodalton 
LGTV  Langat virus 
LN  lymph node 
Luc  luciferase 
MDA5  Melanoma differentiation associated protein 5 
mDCs  myeloid DCs 
MHC  major histocompatibility complex 
ml  milliliter 
µm  micrometer 
MOI  multiplicity of infection 
mTOR  mechanistic Target of Rapamycin 
Myd88  Myeloid differentiation primary response gene 88 
MZ  marginal zone 
Nalt  nasal associated lymphoid tissue 
NDV  Newcastle disease virus 
NETs  neutrophil extracellular trap 
NF-κB  nuclear factor 'kappa-light-chain-enhancer' of activated B-cells 
Nk cells Natural killer cells 
NLRs  NOD-like receptors 
Nm  nanometer 
NOD  nucleotide-binding oligomerization domain 
NS  non-structural protein 
OAS  2'-5'-oligoadenylate synthetase 
OHFV  Omsk hemorrhagic fever virus 
PAMPs Pathogen associated molecular patterns 
pDCs  plasmacytoid DCs 
PKR  Protein kinase R 
Poly I:C polyinosinic-polycytidylic acid 
POWV  Powassan virus 
PRRs  pathogen recognition receptors 
qRT-PCR quantitative real time polymerase chain reaction 
RIG-I  Retinoic acid inducible gene-I 
RLU  relative light units 
RLRs  retinoic acid–inducible gene-I (RIG-I)-like receptors 
RMS  rostral migratory stream 
RNA  ribonucleic acid  
RP  red pulp 
RT  room temperature 
SCID  severe combined immunodeficiency 
SEM  standard error of mean 
SeV  Sendai virus 
Stat  signal transducers and activators of transcription 1 
TANK  TRAF family member-associated NF-kappa-B activator 
TBEV  tick-borne encephalitis virus 
TBK-1  TANK binding kinase-1 
TGF-β  transforming growth factor-beta 
TLR  Toll-like receptors 
TNF-α  Tumor necrosis factor alpha 
TRAF3 TNF receptor associated factor 3 
TRIF  TIR-domain-containing adapter-inducing interferon-β 
TRIM  tripartite motif  
VSV  Vesicular stomatitis virus  
WNV  West Nile virus 
WP  white pulb 
WT  wild type 
ZIKV  Zika virus 
Figure Legend 
 
Fig.1: Jak/Stat pathway signaling by Interferons. 
Fig.2: Basic structure of a Flavivirus. 
Fig.3: Role of RLR and TLR adaptor molecules Myd88, TRIF and IPS-1 in LGTV infection. 
Fig.4: Synergistic effects of TLR and RLR adaptor molecules in LGTV infection. 
Fig.5: The influence of IRFs on the survival of LGTV infection. 
Fig.6: Weight loss of IRF deficient animals infected with LGTV. 
Fig.7: Loss of IRF-7 results in reduced systemic type I IFN responses. 
Fig.8: Local IFN-β induction in LGTV infected reporter mice. 
Fig.9: Induction of IFN-β promotor in secondary lymphoid tissues in the absence of IRFs. 
Fig.10: Size gain of spleens and lymph nodes in LGTV infected animals. 
Fig.11: IRF dependent alterations in spleen dimensions upon LGTV infection. 
Fig.12: Impact of LGTV infection on spleen integrity. 
Fig.13: Histological analysis of spleen integrity upon LGTV infection. 
Fig.14: Differences in myeloid splenocyte populations in the absence of IRFs in LGTV 
infection. 
Fig.15: Alterations in splenocyte frequencies upon LGTV infection. 
Fig.16: IRF-7 exhibits a protective function in spleen. 
Fig.17: IRF-3 protects BMDCs from LGTV infection in vitro. 
Fig.18: Impaired Type I IFN responses in BMDCs in the absence of IRF-7. 
Fig.19: The loss of IRF-7 leads to transient viremia in LGTV infection. 
Fig.20: IRF-7 suppresses LGTV infection in the CNS. 
Fig.21: LGTV is disseminated equally in specific brain structures in the absence of type I 
IFN signaling components. 
Fig.22: Impact of type I IFN deficiencies on immune cell infiltration into the CNS. 
Fig.23: Alterations in IRF deficient microglia in the infected CNS. 
Fig.24: Activation profiles of infiltrating immune cells in the absence of IRFs. 
Fig.25: Alterations in inflammatory cytokine levels in the CNS upon LGTV infection. 
Fig.26: The influence of type I IFN deficiencies on apoptotic processes in the CNS in viral 
infection. 
Fig.27: Altered tropism of LGTV to brain resident cells in the absence of IRF-7. 
Fig.28: Impact of distinct IRFs on local LGTV infection. 
Fig.29: LGTV Infectivity and viral replication in neurons in the absence of IRF-7. 
Fig.30: Type I IFN response in infected neuronal cells in the absence of IRF-7. 
Fig.31: Susceptibility of astrocytes to LGTV infection in the absence of IRFs in vitro. 
Fig.32: Elevated type I IFN response in infected astrocytes in the absence of IRF-7. 
Fig.33: Poly I:C stimulated type I IFN production by IRF-7 deficient astrocytes. 
Fig.34: Type I IFN response elicited by infected microglia in the absence of IRF-7. 
Fig.35: Type I IFN induction visualized in a LGTV infected IFN-β+/∆luc reporter mouse 
model. 
Fig.36: Type I IFN induction is highest in the olfactory bulb of IFN-β+/∆luc IRF-7-/- reporter 
mice. 
Fig.37: In the absence of IRF-7, LGTV is able to persist in the brain. 
Fig.38: FACS Gating of splenocytes. 
Fig.39: FACS Gating of brain isolates. 
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